Data / Research funding / Stem Cell Research - Nonembryonic - Human
Stem Cell Research - Nonembryonic - Human: 1,172 NIH awards ($1.1B) to 288 organizations
1,172 NIH awards ($1.1B) in the NIH spending category Stem Cell Research - Nonembryonic - Human, to 288 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 1,172 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Nebraska Research Network in Functional Genomics | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,833,603 | September 30, 2001 | April 30, 2026 | SORGEN, PAUL L | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $19,528,719 | June 1, 1997 | June 30, 2028 | STEIDL, ULRICH | reporter.nih.gov |
| Baylor College of Medicine Cancer Center - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $19,034,443 | July 1, 2007 | June 30, 2030 | REDDY, PAVAN | reporter.nih.gov |
| The University of Kansas Cancer Center | NIH | National Cancer Institute | 2021 to 2025 | $13,943,269 | July 11, 2012 | June 30, 2027 | JENSEN, ROY A. | reporter.nih.gov |
| Inherited T cell defects: Diagnosis, Mechanisms and Treatments | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $9,040,281 | September 8, 2020 | August 31, 2025 | MARSON, ALEXANDER | reporter.nih.gov |
| Therapeutic gene editing and multimodal imaging in juvenile macular degeneration | NIH | National Eye Institute | 2021 to 2024 | $8,710,741 | June 1, 2020 | May 31, 2026 | TSANG, STEPHEN H | reporter.nih.gov |
| Molecular Circuits in the Hematopoietic Stem Cell Niche | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $6,422,507 | August 15, 2020 | May 31, 2025 | DALEY, GEORGE Q | reporter.nih.gov |
| A regulome and transcriptome atlas of fetal and adult human neurogenesis | NIH | National Institute of Mental Health | 2021 | $5,548,451 | September 20, 2021 | September 19, 2025 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Actin assembly and clathrin-mediated endocytosis in yeast and mammals | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $5,442,792 | July 1, 2016 | June 30, 2026 | DRUBIN, DAVID G | reporter.nih.gov |
| A Human iPSC-based Cell Therapy for Canavan Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $5,276,950 | June 15, 2021 | May 31, 2027 | SHI, YANHONG | reporter.nih.gov |
| The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression | NIH | National Cancer Institute | 2023 to 2025 | $5,126,849 | September 22, 2022 | August 31, 2027 | CHAN, KEITH SYSON | reporter.nih.gov |
| IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease. | NIH | National Institute on Aging | 2021 to 2023 | $4,958,940 | May 1, 2020 | April 30, 2026 | RODGERS, KATHLEEN E. | reporter.nih.gov |
| Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $4,582,323 | September 20, 2018 | July 31, 2024 | STAHL, ANDREAS | reporter.nih.gov |
| Early Pathogenesis of Cystic Fibrosis Related Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $4,452,977 | April 30, 2021 | March 31, 2024 | ENGELHARDT, JOHN F | reporter.nih.gov |
| Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $4,324,679 | September 20, 2018 | July 31, 2023 | TAYLOR, D. LANSING | reporter.nih.gov |
| A generalizable framework for linking single-cell genomic states with cell fate outcomes in hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $4,203,696 | August 15, 2020 | May 31, 2025 | GRIMES, H. LEIGHTON | reporter.nih.gov |
| Small molecule targeting an epigenetic regulator for the treatment of osteoarthritis | NIH | National Institute on Aging | 2021 to 2024 | $4,178,124 | September 30, 2021 | May 2, 2025 | ADORNO, MADDALENA | reporter.nih.gov |
| BMT Survivor Study-2 (BMTSS-2) | NIH | National Cancer Institute | 2021 to 2023 | $3,811,745 | April 1, 2019 | March 31, 2025 | BHATIA, SMITA | reporter.nih.gov |
| Cardiac Lineage-Specific Molecular Mechanisms of Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,682,052 | February 1, 2021 | January 31, 2025 | CHI, NEIL C | reporter.nih.gov |
| 1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,521,212 | September 15, 2020 | August 31, 2025 | BERGER, STUART | reporter.nih.gov |
| Development of a Clinical Hemoglobin Modulator | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $3,473,811 | June 1, 2020 | May 31, 2024 | PERRINE, SUSAN PARK | reporter.nih.gov |
| Immunobiology of Lung Injury and Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,455,443 | January 21, 2019 | December 31, 2024 | MOORE, BETHANY B. | reporter.nih.gov |
| Modulating Stochastic Gene Expression for Cell-fate Control and Therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,366,623 | June 1, 2014 | August 10, 2024 | WEINBERGER, LEOR S | reporter.nih.gov |
| Vascular smooth muscle cell heterogeneity and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,305,617 | March 1, 2021 | December 31, 2025 | SIMONS, MICHAEL | reporter.nih.gov |
| Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,218,917 | August 15, 2015 | June 30, 2026 | JENQ, ROBERT | reporter.nih.gov |
| Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers | NIH | National Cancer Institute | 2021 to 2024 | $3,192,137 | April 1, 2020 | March 31, 2026 | ARMENIAN, SARO | reporter.nih.gov |
| Isolation, characterization and translational development of glioma stem cells | NIH | National Cancer Institute | 2021 to 2023 | $3,189,696 | February 1, 2017 | January 31, 2025 | PARADA, LUIS FERNANDO | reporter.nih.gov |
| Modeling intestinal dysfunction in HIV infection with organoid technology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,127,465 | January 10, 2020 | December 31, 2025 | OTT, MELANIE MARIA | reporter.nih.gov |
| Multimodal Analysis of Gestational Health and Placental Injury in Opioid-Affected Pregnancies | NIH | National Institute on Drug Abuse | 2023 | $3,092,159 | August 15, 2023 | July 30, 2026 | OUYANG, YINGSHI | reporter.nih.gov |
| Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,081,124 | January 16, 2020 | December 31, 2024 | YANG, OTTO O | reporter.nih.gov |
| Promoting Brain Resilience to Alzheimer's Neuropathology | NIH | National Institute on Aging | 2021 to 2024 | $3,062,659 | August 1, 2020 | April 30, 2026 | TAGLIALATELA, GIULIO | reporter.nih.gov |
| MIDAS: MIcroangiopathy, endothelial Damage in Adults undergoing Stem cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,957,506 | August 20, 2020 | July 31, 2026 | VASU, SUMITHIRA | reporter.nih.gov |
| Investigating the effectiveness of COVID-19 testing choices, community engagement, and culturally-embedded mHealth literacy delivery in a medically-underserved, community-based sample | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $2,906,922 | November 11, 2020 | July 31, 2023 | AL-HENDY, AYMAN | reporter.nih.gov |
| Using donor dendritic cells to optimize GvHD and GvL in allogeneic stem cell transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,867,908 | June 1, 2020 | May 31, 2026 | WALLER, EDMUND K | reporter.nih.gov |
| Molecular regulation of native hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,856,222 | February 15, 2016 | December 31, 2025 | CAMARGO, FERNANDO | reporter.nih.gov |
| Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment Following Hematopoietic Stem Cell Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,855,157 | May 1, 2020 | April 30, 2026 | KELLER, MICHAEL DANIEL | reporter.nih.gov |
| Wnt signaling in hematopoietic development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,849,578 | January 1, 2017 | June 30, 2025 | WILLERT, KARL H | reporter.nih.gov |
| JAK-STAT Control of Zika Virus-Induced Fetal Injury | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,840,817 | July 1, 2019 | June 30, 2025 | ADAMS WALDORF, KRISTINA M. | reporter.nih.gov |
| Mechanisms of HIV-associated epithelialintestinal stem cell (ISC) dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,811,833 | July 1, 2020 | June 30, 2025 | KWON, DOUGLAS | reporter.nih.gov |
| Cardiovascular reserve capacity in survivors of hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,785,889 | February 1, 2020 | January 31, 2026 | ARMENIAN, SARO | reporter.nih.gov |
| Common Stem Cell of Origin for Junctional and Gastric Adenocarcinoma | NIH | National Cancer Institute | 2022 to 2024 | $2,754,572 | September 15, 2022 | August 31, 2027 | MCKEON, FRANK D. | reporter.nih.gov |
| Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes | NIH | National Cancer Institute | 2021 to 2024 | $2,742,067 | April 1, 2020 | March 31, 2025 | PARK, CHRISTOPHER Y | reporter.nih.gov |
| Development of FAST-DOSE assay system for the rapid assessment of acute radiation exposure, individual radiosensitivity and injury in victims for a large-scale radiological incident | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,738,709 | February 1, 2020 | January 31, 2026 | TURNER, HELEN C | reporter.nih.gov |
| Conformal Total Body and Marrow Irradiation for Leukemia | NIH | National Cancer Institute | 2021 to 2024 | $2,727,228 | September 13, 2011 | December 31, 2025 | HUI, SUSANTA K | reporter.nih.gov |
| Epigenetic Profiling of circulating cell-free DNA for the Monitoring of Graft-Versus-Host Disease after Hematopoietic Cell Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,694,538 | January 13, 2020 | December 31, 2025 | DE VLAMINCK, IWIJN | reporter.nih.gov |
| In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,680,549 | June 8, 2022 | April 1, 2025 | ADAIR, JENNIFER EILEEN | reporter.nih.gov |
| How the 3D Architecture of the Brain Shapes Cancer Cell Fate Decisions | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,670,000 | September 30, 2021 | August 31, 2026 | FILBIN, MARIELLA GRUBER | reporter.nih.gov |
| Transcriptional Control During Erythropoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,660,464 | September 16, 2013 | October 31, 2025 | RANISH, JEFFREY A | reporter.nih.gov |
| Genomics of bone and body composition traits in children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,651,635 | August 7, 2020 | June 30, 2026 | ZEMEL, BABETTE S | reporter.nih.gov |
| Comparative Genomics of Precursor Diversity and Function | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,631,720 | April 1, 2021 | February 28, 2026 | HAYDAR, TARIK F | reporter.nih.gov |
| An Integrated In Vitro 3D Model of Human Bone Marrow and Peripheral Infection | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $2,620,380 | September 15, 2021 | May 31, 2026 | GEORGE, STEVEN CARL | reporter.nih.gov |
| Rectifying splicing mutations in blood disorders by gene editing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,584,045 | December 20, 2019 | November 30, 2023 | BAUER, DANIEL EVAN | reporter.nih.gov |
| Targeted genetic engineering of B cells to induce protective antibody responses to viral pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,577,835 | July 5, 2022 | June 30, 2027 | ADAIR, JENNIFER EILEEN | reporter.nih.gov |
| The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,563,053 | August 1, 2020 | July 31, 2025 | HUARD, JOHNNY | reporter.nih.gov |
| Phase1/2a Clinical Trial of RPESC-derived RPE Transplantation as Therapy for Non-exudative Age-related Macular Degeneration | NIH | National Eye Institute | 2021 to 2024 | $2,549,156 | September 30, 2020 | September 29, 2025 | STERN, JEFFREY H | reporter.nih.gov |
| Tissue chips for precision treatment of catecholaminergic polymorphic ventricular tachycardia | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,546,193 | September 1, 2020 | July 31, 2025 | PU, WILLIAM TSWENCHING | reporter.nih.gov |
| The Molecular Regulation of Horizontal Basal Cell Activation in the Olfactory Epithelium | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,546,159 | February 7, 2020 | January 31, 2026 | SCHWOB, JAMES E. | reporter.nih.gov |
| Methamphetamine Effect on HIV Persistence | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,535,677 | July 1, 2020 | May 31, 2025 | KAUL, MARCUS | reporter.nih.gov |
| Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,529,105 | August 24, 2017 | July 31, 2024 | WAYNE, ALAN S. | reporter.nih.gov |
| Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,527,128 | September 20, 2016 | May 31, 2025 | SNOECK, HANS-WILLEM E | reporter.nih.gov |
| The Genetic Architecture of Human Facial Morphology | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,521,882 | July 14, 2017 | February 28, 2026 | WEINBERG, SETH M | reporter.nih.gov |
| Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia | NIH | National Cancer Institute | 2021 to 2024 | $2,518,197 | July 1, 2020 | June 30, 2025 | DEININGER, MICHAEL W. | reporter.nih.gov |
| Editing Alveolar Progenitor Cells for Correction of Monogenic Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,504,499 | September 23, 2016 | May 31, 2025 | WHITSETT, JEFFREY A | reporter.nih.gov |
| Fine-scale Spatiotemporal Mapping of Cellular Regulatory Networks Directing Heart Development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,499,248 | August 1, 2020 | July 31, 2025 | CHI, NEIL C | reporter.nih.gov |
| Using a SMART Design to Optimize PTSD Symptom Management Strategies Among Cancer Survivors | NIH | National Cancer Institute | 2021 to 2024 | $2,482,100 | December 1, 2019 | November 30, 2025 | SMITH, SOPHIA K. | reporter.nih.gov |
| Epigenetics and 3D Structure of miR-10b/HoxD Locus in the Brain and Malignant Glioma | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,479,682 | September 15, 2020 | July 31, 2025 | KRICHEVSKY, ANNA M. | reporter.nih.gov |
| Characterization of Neural Stem Cells in Adult Brain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,454,507 | April 1, 1990 | March 31, 2026 | ALVAREZ-BUYLLA, ARTURO | reporter.nih.gov |
| Emergency Myelopoiesis Pathways in the Control of Blood Production | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,450,418 | April 1, 2017 | March 31, 2025 | PASSEGUE, EMMANUELLE | reporter.nih.gov |
| Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,438,515 | January 5, 2021 | December 31, 2025 | HSU, KATHARINE C | reporter.nih.gov |
| A Gata456 Pipeline of Discovery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,432,169 | January 10, 2017 | December 31, 2023 | EVANS, TODD R | reporter.nih.gov |
| Stem cells for therapeutics discovery in genetic blood disorders | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,429,809 | September 23, 2016 | May 31, 2025 | DALEY, GEORGE Q | reporter.nih.gov |
| The role of mitochondria in hematopoietic stem cell self-renewal | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,417,109 | January 1, 2021 | December 31, 2024 | FILIPPI, MARIE-DOMINIQUE | reporter.nih.gov |
| Role of O-GlcNAcome on Breast Cancer Initiating Cells | NIH | National Cancer Institute | 2021 to 2024 | $2,414,370 | March 1, 2020 | February 28, 2025 | REGINATO, MAURICIO J. | reporter.nih.gov |
| Mathematical ecology models of host-microbiota interaction in auto microbiota transplants (auto-FMT) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,414,163 | February 1, 2019 | January 31, 2024 | XAVIER, JOAO | reporter.nih.gov |
| Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,388,592 | September 21, 2016 | May 31, 2025 | CHAPMAN, HAROLD A | reporter.nih.gov |
| Regulation of Ribosome Biogenesis in Hematopoietic Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,385,337 | September 18, 2020 | August 31, 2025 | TONG, WEI | reporter.nih.gov |
| The 4D nucleome of muscle regeneration in ischemia-induced tissue damage and repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,377,116 | September 20, 2020 | August 31, 2025 | DIAO, YARUI | reporter.nih.gov |
| Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,376,851 | September 1, 2020 | July 31, 2026 | KIM, DEOK-HO | reporter.nih.gov |
| Multipotent ABCB5-positive cell therapeutics for corneal disease | NIH | National Eye Institute | 2021 to 2022 | $2,352,662 | April 1, 2018 | January 31, 2024 | FRANK, NATASHA Y | reporter.nih.gov |
| Vsx2 Dependent Regulation of Retinal Progenitor Cell Properties | NIH | National Eye Institute | 2021 to 2024 | $2,351,133 | August 1, 2003 | July 31, 2025 | LEVINE, EDWARD M | reporter.nih.gov |
| Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,348,652 | February 13, 2020 | July 31, 2025 | LANGE, CAROL A | reporter.nih.gov |
| Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,334,876 | July 15, 2020 | June 30, 2026 | FREEDMAN, BENJAMIN SOLOMON | reporter.nih.gov |
| Integrated Cellular and Tissue Engineering for Ischemic Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,333,316 | September 15, 2016 | May 31, 2025 | ZHANG, JIANYI | reporter.nih.gov |
| Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality | NIH | National Cancer Institute | 2021 to 2024 | $2,315,110 | September 3, 2018 | January 31, 2026 | SORROR, MOHAMED | reporter.nih.gov |
| A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,306,928 | July 15, 2020 | June 30, 2026 | TAYLOR, D. LANSING | reporter.nih.gov |
| T cell invasion of the stem cell compartment during immune-mediated GI damage | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,299,846 | January 1, 2021 | December 31, 2025 | HANASH, ALAN M | reporter.nih.gov |
| Transcriptional Regulation of Lung Alveolar Regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,270,370 | February 1, 2021 | December 31, 2024 | MORRISEY, EDWARD E | reporter.nih.gov |
| Mechanisms of oxysterol-induced oligodendrogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,255,433 | December 15, 2019 | November 30, 2024 | BENNER, ERIC J | reporter.nih.gov |
| Tympanic membrane progenitor cells in homeostasis in injury | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,250,702 | April 25, 2020 | March 31, 2026 | TWARD, AARON | reporter.nih.gov |
| Development of ASH1L inhibitors for acute leukemia | NIH | National Cancer Institute | 2021 to 2024 | $2,243,021 | December 1, 2019 | November 30, 2025 | GREMBECKA, JOLANTA | reporter.nih.gov |
| PCTC Administrative Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,233,284 | September 20, 2016 | May 31, 2025 | TERRIN, MICHAEL L | reporter.nih.gov |
| Intraoperative bioprinting of composite tissues with zonal stratification for craniomaxillofacial reconstruction | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,227,502 | January 1, 2020 | December 31, 2025 | OZBOLAT, IBRAHIM | reporter.nih.gov |
| Stem Cells and Aging | NIH | National Institute of General Medical Sciences | 2021 | $2,226,780 | July 1, 2017 | June 30, 2024 | QUESENBERRY, PETER J. | reporter.nih.gov |
| Multiplex base/prime editors for in vivo selection of modified HSPCs in hemoglobinopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,218,334 | January 17, 2017 | December 31, 2025 | KIEM, HANS-PETER | reporter.nih.gov |
| AML mutation-guided drugging of DNA repair | NIH | National Cancer Institute | 2021 to 2024 | $2,200,960 | March 1, 2020 | January 31, 2026 | SKORSKI, TOMASZ | reporter.nih.gov |
| A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,198,065 | July 1, 2020 | November 30, 2025 | SVENDSEN, CLIVE NIELS | reporter.nih.gov |
| Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia | NIH | National Cancer Institute | 2021 to 2024 | $2,173,391 | June 1, 2020 | May 31, 2025 | ABDEL-WAHAB, OMAR | reporter.nih.gov |
| Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress | NIH | National Cancer Institute | 2021 to 2022 | $2,160,078 | September 17, 2018 | August 31, 2024 | WILLEY, CHRISTOPHER D | reporter.nih.gov |
| Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer | NIH | National Cancer Institute | 2021 to 2023 | $2,159,273 | June 4, 2018 | November 30, 2023 | DUCKETT, DEREK RONALD | reporter.nih.gov |
| Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling | NIH | National Cancer Institute | 2021 to 2024 | $2,143,591 | September 3, 2020 | May 31, 2026 | CHAPKIN, ROBERT STEPHEN | reporter.nih.gov |
| Manganese exposure susceptibility as a modifier of excitotoxicity in Alzheimer's Disease | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,124,884 | February 1, 2020 | October 31, 2025 | HARRISON, FIONA EDITH | reporter.nih.gov |
| Human CDX2 Cells and Cardiac Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,116,925 | July 21, 2020 | May 31, 2025 | CHAUDHRY, HINA W | reporter.nih.gov |
| Altered Hippocampal Neurogenesis and Cognition via Maneb-mediated Changes in the Thiol Redox Proteome. | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $2,104,664 | March 1, 2017 | February 28, 2026 | ROEDE, JAMES R | reporter.nih.gov |
| Targeting cancer stem cells in JAK2V617F induced neoplasm | NIH | National Cancer Institute | 2021 to 2024 | $2,096,959 | February 15, 2020 | January 31, 2025 | LI, SHAOGUANG | reporter.nih.gov |
| Ex vivo analysis of human brain tumor cells in a microvascular niche model | NIH | National Cancer Institute | 2021 to 2024 | $2,082,785 | February 4, 2020 | January 31, 2025 | FAN, RONG | reporter.nih.gov |
| Targeting the Circadian Rhythm in Glioblastoma Stem Cells (R01CA238662) | NIH | National Cancer Institute | 2021 to 2024 | $2,081,567 | July 1, 2021 | November 30, 2024 | RICH, JEREMY N | reporter.nih.gov |
| Function of RUNX1 in diverse Down syndrome tissues | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,081,565 | September 1, 2023 | August 31, 2024 | ALLEN, MARY A | reporter.nih.gov |
| Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection | NIH | National Eye Institute | 2021 to 2024 | $2,079,783 | January 1, 2021 | December 31, 2025 | ARUMUGASWAMI, VAITHILINGARAJA | reporter.nih.gov |
| Cellular Reservoirs of HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,070,157 | September 23, 2019 | August 31, 2025 | COLLINS, KATHLEEN L. | reporter.nih.gov |
| Mechanisms regulating functional heterogeneity of subcutaneous adipose tissues in women | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,068,261 | July 8, 2019 | April 30, 2025 | FRIED, SUSAN K | reporter.nih.gov |
| Mechanistic Understanding for the Role of Lin28b in Pancreatic Cancer Progression | NIH | National Cancer Institute | 2021 to 2023 | $2,060,694 | February 19, 2019 | January 31, 2024 | MOSTOSLAVSKY, RAUL | reporter.nih.gov |
| Treating Kidney Injury by Modulating Heat Shock Proteins Using Soundwaves Combined with Mesenchymal Stem Cells and Their Extracellular Vesicles | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,048,853 | August 30, 2021 | July 31, 2025 | THAKOR, AVNESH SINH | reporter.nih.gov |
| Investigating epigenetic mechanisms in Down syndrome using human cellular models | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $2,034,753 | April 5, 2023 | March 31, 2026 | BARRETT, LINDY ELISE | reporter.nih.gov |
| Neurobehavioral, cognitive, and mechanistic effects of intranasally administered neural stem cells and environmental enrichment after cortical impact injury in rats | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,032,869 | September 1, 2021 | August 31, 2025 | KLINE, ANTHONY E. | reporter.nih.gov |
| Targeted Small Molecule Inhibitors for Inv(16) Leukemia | NIH | National Cancer Institute | 2021 to 2023 | $2,012,862 | December 1, 2018 | November 30, 2024 | BUSHWELLER, JOHN HACKETT | reporter.nih.gov |
| Chromatin Organization Regulates Osteogenesis | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,010,351 | January 6, 2020 | December 31, 2024 | STEIN, GARY S. | reporter.nih.gov |
| Exosome educated monocytes for acute radiation syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,007,828 | August 1, 2021 | July 31, 2025 | CAPITINI, CHRISTIAN | reporter.nih.gov |
| Matching panels of in vivo and in vitro model system of pediatric brain tumors | NIH | National Cancer Institute | 2021 to 2024 | $2,001,657 | March 3, 2020 | February 28, 2026 | LI, XIAONAN | reporter.nih.gov |
| TOPIC 414 : SYNTHETIC BIOLOGY GENE CIRCUITS FOR CANCER THERAPY | NIH | National Cancer Institute | 2021 | $1,999,993 | August 1, 2021 | July 31, 2023 | LEE, GARY | reporter.nih.gov |
| Phase 1/2a Clinical Study of Descartes-30 in Acute Respiratory Distress Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,998,233 | May 1, 2021 | April 30, 2024 | STEWART, CHARLES ANDREW | reporter.nih.gov |
| Vascular Remodeling in the Bone Marrow Leukemic Niche: A Therapeutic Target? | NIH | National Cancer Institute | 2021 to 2024 | $1,996,349 | April 1, 2020 | March 31, 2026 | MARCUCCI, GUIDO | reporter.nih.gov |
| In Vivo Proof of Concept and Target Identification Using Small Molecule Stimulators of Brown Adipogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,988,528 | July 1, 2020 | July 31, 2024 | BOSS, OLIVIER | reporter.nih.gov |
| InflammaGut: a drug-screenable co-culture system using gut-associated lymphocytes and autologous primary human gut epithelium that reports inflammation | NIH | National Center for Advancing Translational Sciences | 2022 to 2023 | $1,980,716 | May 1, 2022 | January 31, 2025 | THELIN, BILL | reporter.nih.gov |
| Modeling the Glioblastoma Microenvironment to Uncover Progression Mechanisms and Therapeutic Targets | NIH | National Cancer Institute | 2021 to 2024 | $1,980,275 | May 1, 2020 | April 30, 2026 | BRAT, DANIEL J | reporter.nih.gov |
| Delirium in Children Undergoing Hematopoietic Stem Cell Transplants | NIH | National Cancer Institute | 2021 to 2024 | $1,975,976 | September 1, 2020 | May 31, 2026 | TRAUBE, CHANI | reporter.nih.gov |
| Gastrin Regulation of Gastric Antral Stem and Corpus Progenitor Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,975,882 | September 23, 2021 | August 31, 2025 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| Combined bioprinting with stem cell technology to regenerate skin burn wounds | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,972,718 | August 1, 2021 | May 31, 2026 | SQUARIZE, CRISTIANE | reporter.nih.gov |
| Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis | NIH | National Cancer Institute | 2021 to 2024 | $1,972,648 | May 1, 2010 | February 28, 2026 | SHEMBADE, NOULA DATTU | reporter.nih.gov |
| Engineered Neuroprotective Stem-Cell Exosomes for In Utero Spina Bifida Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,972,069 | September 30, 2020 | August 31, 2025 | FARMER, DIANA LEE | reporter.nih.gov |
| Tumor matrix remodeling in anti-myeloma immunity and immunotherapy | NIH | National Cancer Institute | 2021 to 2024 | $1,950,659 | July 1, 2020 | December 31, 2024 | ASIMAKOPOULOS, FOTIOS | reporter.nih.gov |
| Discovery of small molecule regulators of atrial cardiomyocyte action potential duration to restore normal cardiac rhythm in atrial fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,950,000 | June 10, 2021 | August 31, 2025 | COLAS, ALEXANDRE ROMAIN | reporter.nih.gov |
| DOT1L, reconstitution of plasmacytoid dendritic cells and alloimmunity | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,948,900 | November 23, 2021 | March 31, 2026 | ZHANG, YI | reporter.nih.gov |
| Investigating the effects of aerobic and resistance training in vivo on skeletal muscle metabolism in vitro in primary human muscle cells (MoTrMyo) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,938,650 | August 1, 2019 | May 31, 2026 | SPARKS, LAUREN MARIE | reporter.nih.gov |
| Development of a DCLK1 siRNA Nanoparticle as Targeted Therapy to Treat Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,935,472 | August 22, 2018 | July 31, 2024 | DE OLIVEIRA, ELISEU O. | reporter.nih.gov |
| Maternal programming of the stem cell-basophil axis for asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,932,227 | July 20, 2020 | June 30, 2025 | GORSKA, MAGDALENA MARIA | reporter.nih.gov |
| Mechanisms Controlling Expansion and Lineage Specification of Airway Progenitors in Development and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,919,136 | January 1, 2017 | June 30, 2023 | CARDOSO, WELLINGTON V. | reporter.nih.gov |
| Mechanisms governing metastatic dormancy and reactivation | NIH | National Cancer Institute | 2021 to 2022 | $1,915,493 | August 1, 2016 | July 31, 2023 | GIANCOTTI, FILIPPO G | reporter.nih.gov |
| Development of a Bio-tissue Oxygenation Nanophosphor Enabled Sensing (BONES) system for Quantifying Hypoxia in Bone Marrow | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,915,320 | June 1, 2021 | February 28, 2025 | YUN, WENBING | reporter.nih.gov |
| Defining malignant hematopoiesis via single-cell multi-omics | NIH | Office of the Director, National Institutes of Health | 2021 to 2024 | $1,910,784 | September 15, 2020 | August 31, 2025 | NAM, SEUNG HA | reporter.nih.gov |
| Single-cell proteomic identification of novel markers of senescence | NIH | National Cancer Institute | 2023 to 2024 | $1,902,334 | September 22, 2021 | August 31, 2025 | DOU, ZHIXUN | reporter.nih.gov |
| Brain Development in Down Syndrome during Fetal and Early Postnatal Ages | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $1,896,457 | September 18, 2024 | August 31, 2027 | TAKAHASHI (OKI), EMI | reporter.nih.gov |
| Determining lineage decisions and gene regulatory networks governing the generation of key progenitor cell types during early human brain development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,890,725 | April 7, 2020 | March 31, 2025 | RAMANATHAN, SHARAD | reporter.nih.gov |
| Home-based Autologous Hematopoietic Stem Cell Transplantation to Improve Outcomes and Decrease Costs | NIH | National Institute on Aging | 2021 to 2024 | $1,889,750 | June 1, 2020 | June 1, 2024 | SUNG, ANTHONY | reporter.nih.gov |
| A 2D Intestinal Crypt Platform for Compound Screens | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $1,888,698 | July 1, 2021 | July 31, 2025 | SIMS, CHRISTOPHER ELDRIDGE | reporter.nih.gov |
| A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,880,006 | March 19, 2018 | July 31, 2024 | GILKESON, GARY S | reporter.nih.gov |
| Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,872,035 | September 1, 2020 | May 31, 2026 | BOTA, DANIELA ANNENELIE | reporter.nih.gov |
| Defining genetic and metabolic requirements of aggressive breast cancer | NIH | National Cancer Institute | 2021 to 2024 | $1,861,232 | April 1, 2020 | March 31, 2026 | WALTZ, SUSAN E | reporter.nih.gov |
| Prenatal metal mixtures and neurodevelopment: Role of placental extracellular microRNAs | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $1,860,956 | June 1, 2019 | May 31, 2024 | WRIGHT, ROSALIND J | reporter.nih.gov |
| Transcriptional and epigenetic basis of lung epithelial cell fate | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,860,726 | July 1, 2020 | December 31, 2023 | CHEN, JICHAO | reporter.nih.gov |
| Targeting dysregulated transcriptome as therapy for post-myeloproliferative neoplasm (MPN) sAML | NIH | National Cancer Institute | 2021 to 2024 | $1,860,616 | April 13, 2020 | March 31, 2025 | BHALLA, KAPIL | reporter.nih.gov |
| NF-kB Regulation of the Muscle Microenvironment in Cancer Cachexia | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,849,772 | February 26, 2020 | June 30, 2025 | GUTTRIDGE, DENIS C | reporter.nih.gov |
| Regulators of Development and Quiescence in the Human Muscle Stem Cell Lineage | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,846,023 | September 25, 2019 | August 31, 2025 | POURQUIE, OLIVIER | reporter.nih.gov |
| Multimodal approach investigating the immunomodulatory effect ofneural stem cells in stroke recovery | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,840,475 | August 1, 2008 | January 31, 2026 | STEINBERG, GARY K | reporter.nih.gov |
| Patient-derived Models of Synaptic Pruning in Schizophrenia | NIH | National Institute of Mental Health | 2021 to 2023 | $1,832,595 | July 19, 2019 | April 30, 2025 | PERLIS, ROY H. | reporter.nih.gov |
| Targeting Clonal Hematopoiesis of Indeterminate Potential using Human Genetics | NIH | Office of the Director, National Institutes of Health | 2021 to 2024 | $1,830,957 | September 15, 2020 | August 31, 2025 | BICK, ALEXANDER | reporter.nih.gov |
| Relationships between parity, breastfeeding and ER- breast cancer in African American women: Elucidating the biologic underpinnings at the molecular and cellular level. | NIH | National Cancer Institute | 2021 to 2023 | $1,829,705 | December 4, 2018 | November 30, 2024 | AMBROSONE, CHRISTINE B. | reporter.nih.gov |
| Targeting breast cancer stem cells | NIH | National Cancer Institute | 2021 to 2022 | $1,826,944 | February 1, 2016 | January 31, 2024 | WICHA, MAX S. | reporter.nih.gov |
| Gene Networks promoting adipocyte cell differentiation and function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,817,690 | April 1, 2020 | March 31, 2025 | SEALE, PATRICK | reporter.nih.gov |
| Hippo Signaling Effector and Placentation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,816,512 | April 1, 2020 | March 31, 2026 | PAUL, SOUMEN | reporter.nih.gov |
| Investigating tau and ApoE4-mediated alterations in oligodendrocyte progenitor cells | NIH | National Institute on Aging | 2022 to 2024 | $1,813,828 | June 1, 2022 | February 28, 2028 | COOK, CASEY N | reporter.nih.gov |
| Preclinical development of ONCT-505, an Androgen Receptor Antagonist and Degrader, as New Potential Therapeutic for Kennedy's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $1,810,779 | March 15, 2023 | February 28, 2025 | KRISHNAN, RAJESH | reporter.nih.gov |
| Targeting alternative splicing for TCR discovery in small cell carcinomas | NIH | National Cancer Institute | 2021 to 2022 | $1,809,996 | September 21, 2018 | August 31, 2024 | WITTE, OWEN N. | reporter.nih.gov |
| Analysis of E-selectin Ligands of Human Acute Leukemia Cells and their Biology in Leukemogenesis | NIH | National Cancer Institute | 2021 to 2023 | $1,799,538 | July 17, 2019 | June 30, 2025 | SACKSTEIN, ROBERT | reporter.nih.gov |
| Systematic dissection of gut cellular circuits [at single cell resolution] | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $1,795,970 | August 1, 2017 | May 31, 2023 | XAVIER, RAMNIK J | reporter.nih.gov |
| Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,795,134 | July 1, 2010 | June 30, 2027 | NING, MINGMING | reporter.nih.gov |
| The unique roles of the GTP-binding/protein crosslinking enzyme transglutaminase-2 and signaling partners in aggressive cancers | NIH | National Cancer Institute | 2021 to 2024 | $1,783,848 | December 4, 2015 | April 30, 2026 | CERIONE, RICHARD A. | reporter.nih.gov |
| "Clinical Trials" on a Premature Vascular Aging-on-a-Chip Model | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $1,780,604 | August 1, 2020 | July 31, 2025 | ZHANG, Y. SHRIKE | reporter.nih.gov |
| PPM1D in Clonal Hematopoiesis and Malignancies | NIH | National Cancer Institute | 2021 to 2023 | $1,774,910 | July 1, 2019 | June 30, 2025 | GOODELL, MARGARET A. | reporter.nih.gov |
| Mechanisms Mediating Osseointegration of 3D Printed Titanium Constructs | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,766,718 | January 7, 2019 | December 31, 2024 | BOYAN, BARBARA D. | reporter.nih.gov |
| Understanding and Using Variation in Source Materials for MSC Fabrication | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $1,762,373 | August 14, 2019 | April 30, 2025 | MUSCHLER, GEORGE F | reporter.nih.gov |
| Phase I/II clinical trial of HDAC inhibition for GVHD prevention in children, adolescents, and young adults | NIH | National Cancer Institute | 2021 to 2024 | $1,755,671 | June 1, 2020 | May 31, 2026 | CHOI, SUNG WON | reporter.nih.gov |
| Translational Control of Leukemia Stem Cells - Resubmission - 1 | NIH | National Cancer Institute | 2021 to 2024 | $1,751,741 | July 1, 2020 | June 30, 2025 | PARK, CHRISTOPHER Y | reporter.nih.gov |
| NRSA Training Core | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $1,743,177 | August 13, 2015 | March 31, 2026 | KOTTON, DARRELL N. | reporter.nih.gov |
| Using hiPSCs to develop physiologically-relevant outer retina tissue mimetics | NIH | National Eye Institute | 2022 to 2024 | $1,738,353 | September 30, 2022 | August 31, 2025 | SINGH, RUCHIRA | reporter.nih.gov |
| Optimal Tissue Engineering Approach for Treating Injured Vocal Folds | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2023 | $1,735,877 | December 1, 2018 | November 30, 2025 | FREYTES, DONALD O | reporter.nih.gov |
| DNA Methylation at N6-Adenine in Placental Trophoblast Development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $1,734,519 | August 1, 2020 | April 30, 2026 | JIANG, ZONGLIANG | reporter.nih.gov |
| Role of an Integrator-EGR axis in the regulation of myeloid enhancers | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,732,815 | February 1, 2019 | November 30, 2024 | GARDINI, ALESSANDRO | reporter.nih.gov |
| Clickable Microgel Scaffolds for MSC Expansion and Delivery | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $1,727,811 | March 5, 2019 | February 28, 2025 | ANSETH, KRISTI S. | reporter.nih.gov |
| Mechanisms of actions(s) of simvastatin in uterine leiomyoma | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,719,127 | August 1, 2018 | July 31, 2025 | BORAHAY, MOSTAFA A. | reporter.nih.gov |
| Imaging and Blood Biomarkers to Predict Graft Failure after HSCT | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,715,532 | September 25, 2019 | July 31, 2025 | WILLIAMS, KIRSTEN | reporter.nih.gov |
| Investigating the direct reprogramming of fibroblasts into skeletal muscle progenitors | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,713,632 | August 15, 2020 | May 31, 2025 | HOCHEDLINGER, KONRAD | reporter.nih.gov |
| Regulation and function of hematopoietic stem cell niches | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,682,486 | March 1, 2000 | December 31, 2024 | GRITSMAN, KIRA | reporter.nih.gov |
| Restoration of myocardial reparative function of diabetic progenitor cells by epigenetic modulation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,680,897 | December 10, 2019 | November 30, 2025 | KISHORE, RAJ | reporter.nih.gov |
| Efficient and scalable microfluidic gene delivery to hematopoietic stem cells to treat blood diseases | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,680,456 | August 15, 2019 | June 30, 2024 | HAN, SEWOON | reporter.nih.gov |
| Molecular and Epigenetic Control of Wnt/b-catenin-mediated oncogenesis by KDM4B | NIH | National Cancer Institute | 2021 to 2024 | $1,675,571 | February 1, 2020 | January 31, 2025 | WANG, CUN-YU | reporter.nih.gov |
| In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,675,237 | September 15, 2021 | August 31, 2023 | GOLIGHTLY, LINNIE | reporter.nih.gov |
| MPN-inducing mutations as biomarkers of synthetic lethality | NIH | National Cancer Institute | 2021 to 2024 | $1,674,115 | June 1, 2020 | May 31, 2026 | SKORSKI, TOMASZ | reporter.nih.gov |
| The function and underlying mechanism of TET1 in myelodysplastic syndromes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,663,013 | March 10, 2020 | December 31, 2023 | CHEN, JIANJUN | reporter.nih.gov |
| MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies | NIH | National Cancer Institute | 2021 to 2022 | $1,659,300 | September 20, 2018 | August 31, 2024 | KUFE, DONALD W. | reporter.nih.gov |
| Resetting immune homeostasis: a non-invasive approach towards HIV eradication | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $1,648,370 | August 9, 2017 | July 31, 2025 | SEKALY, RAFICK PIERRE | reporter.nih.gov |
| AMYLOIDOGENIC INDUCTION OF CELLULAR SENESCENCE IN ALZHEIMER'S DISEASE | NIH | National Institute on Aging | 2021 to 2024 | $1,645,988 | August 1, 2020 | July 31, 2025 | MIRANKER, ANDREW D. | reporter.nih.gov |
| Wnt5a, a New Diabetic Corneal Marker Related to Wound Healing | NIH | National Eye Institute | 2021 to 2024 | $1,644,857 | September 30, 2020 | August 31, 2025 | LJUBIMOV, ALEXANDER V | reporter.nih.gov |
| Biomechanical Activation of Yap Induces Hematopoietic Stem Cell Production | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,632,318 | April 1, 2020 | March 31, 2026 | NORTH, TRISTA E. | reporter.nih.gov |
| Imaging of Hematologic and Oncologic Disorders | NIH | National Cancer Institute | 2021 to 2022 | $1,625,586 | May 1, 2016 | April 30, 2024 | ROSS, BRIAN D. | reporter.nih.gov |
| A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC) | NIH | National Cancer Institute | 2022 to 2024 | $1,622,400 | June 10, 2022 | May 31, 2027 | CHANG, JENNY C-N | reporter.nih.gov |
| Development of a microphysiologic system to assay the interaction of the human colonic epithelium on Clostridium difficile | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,620,228 | March 1, 2020 | December 31, 2024 | ALLBRITTON, NANCY L. | reporter.nih.gov |
| Developing next generation synthetic nucleic acid analogous for sickle cell disease gene editing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,610,000 | December 15, 2019 | November 30, 2025 | BAHAL, RAMAN | reporter.nih.gov |
| Mechanisms for Impaired Adaptation to Aerobic Exercise with Metabolic Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,607,583 | September 15, 2020 | July 14, 2024 | LESSARD, SARAH | reporter.nih.gov |
| The Role of RHOA in Diffuse Gastric Cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,607,160 | June 8, 2018 | December 31, 2022 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| Inflammatory mechanisms responsible for the development of multiple organ dysfunction in pediatric patients following allogeneic blood and marrow transplantation (BMT). | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,598,857 | February 1, 2020 | January 31, 2026 | COOKE, KENNETH R | reporter.nih.gov |
| New sterol-binding targets and optimized EBP inhibitors for promoting remyelination | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,598,057 | May 1, 2020 | January 31, 2025 | ADAMS, DREW JAMES | reporter.nih.gov |
| Lineage specifiers governing pancreatic cancer growth and molecular subtype | NIH | National Cancer Institute | 2021 to 2024 | $1,576,922 | June 1, 2020 | May 31, 2026 | SNYDER, ERIC LEE | reporter.nih.gov |
| Enterovirus Infection of Polarized Intestinal Cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,575,846 | July 1, 2021 | May 31, 2026 | COYNE, CAROLYN B | reporter.nih.gov |
| Nanotechnology for targeted therapy and fundamental understanding oftherapeutic resistance in triple negative breast cancer | NIH | National Cancer Institute | 2021 to 2024 | $1,574,340 | April 1, 2020 | March 31, 2026 | HE, XIAOMING | reporter.nih.gov |
| Cone subtype specification in human retinas and organoids | NIH | National Eye Institute | 2021 to 2023 | $1,566,838 | January 1, 2020 | December 31, 2024 | JOHNSTON, ROBERT JOHN | reporter.nih.gov |
| Epigenetic Regulation of Bone Regeneration in Inflammatory Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,566,325 | July 8, 2019 | June 30, 2025 | SHEN, JIE | reporter.nih.gov |
| BCL11B activation as an approach for enhancing the efficacy of immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,566,114 | February 11, 2021 | July 1, 2024 | PAREKH, CHINTAN | reporter.nih.gov |
| Human brain multi-omics to decipher major depression pathophysiology | NIH | National Institute of Mental Health | 2023 to 2024 | $1,565,284 | September 1, 2023 | June 30, 2028 | BOLDRINI, MAURA | reporter.nih.gov |
| Oncogenic tyrosine kinases inhibitors abrogate DNA repair and sensitive leukemias to PARP inhibitors | NIH | National Cancer Institute | 2021 to 2024 | $1,562,631 | April 1, 2020 | March 31, 2026 | SKORSKI, TOMASZ | reporter.nih.gov |
| Role of ER Stress and Fatty Acid Metabolism in Glioma Stem Cells | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,562,282 | September 15, 2020 | July 31, 2026 | BADR, CHRISTIAN ELIAS | reporter.nih.gov |
| Atypical TDP43 isoforrms driving neurodegeneration in FTD/ALS | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,560,000 | December 1, 2019 | November 30, 2025 | BARMADA, SAMI | reporter.nih.gov |
| Heat Shock Transcription Factor 1 Specifically Regulates AML Stem Cell Self-Renewal | NIH | National Cancer Institute | 2021 to 2024 | $1,558,730 | December 15, 2019 | May 31, 2025 | ZHAO, CHEN | reporter.nih.gov |
| A NOVEL LINEAGE SPECIFIC METASTASIS PATHWAY IN LUNG CANCER | NIH | National Cancer Institute | 2021 to 2024 | $1,555,447 | December 1, 2012 | November 30, 2025 | NGUYEN, DON X | reporter.nih.gov |
| Targeting DNA repair to eradicate TKi-refractory/resistant CML and Ph+ALL | NIH | National Cancer Institute | 2021 to 2024 | $1,543,188 | August 12, 2014 | February 28, 2026 | SKORSKI, TOMASZ | reporter.nih.gov |
| Role of VGLL1 in human placental development and trophoblast specification | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,539,133 | February 1, 2019 | January 31, 2025 | SONCIN, FRANCESCA | reporter.nih.gov |
| Mechanisms of Posterior Heart Field Development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,535,814 | August 1, 2020 | July 31, 2024 | CHI, NEIL C | reporter.nih.gov |
| Ex vivo hematopoietic stem cell growth mediated by the heat shock response | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,534,861 | March 1, 2020 | December 31, 2024 | SIGNER, ROBERT A.J. | reporter.nih.gov |
| Molecular, Epigenetic and Genomic Approaches to Understand Mechanisms of Aging in the Human Testis | NIH | National Institute on Aging | 2021 to 2024 | $1,525,000 | September 30, 2020 | May 31, 2025 | CAIRNS, BRADLEY R. | reporter.nih.gov |
| Multiscale Models of Wound Cell Plasticity for Regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,520,232 | September 1, 2018 | June 30, 2024 | NIE, QING | reporter.nih.gov |
| Sustained delivery of therapeutics to the visual system using genetically modified autologous mesenchymal stem cells to treat blinding diseases | NIH | National Eye Institute | 2021 to 2023 | $1,519,053 | May 1, 2019 | April 30, 2025 | WHITING, REBECCA EH | reporter.nih.gov |
| Understanding the neurodevelopmental role and mechanism of histone demethylase JMJD3 | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,506,714 | July 15, 2020 | April 30, 2025 | LIM, DANIEL A | reporter.nih.gov |
| Assessment of Metabolites Among Asymptomatic Precursor and Malignant Monoclonal Gammopathies | NIH | National Cancer Institute | 2021 to 2024 | $1,503,881 | March 1, 2021 | February 28, 2026 | GONSALVES, WILSON | reporter.nih.gov |
| Development of Novel MNK Inhibitors for Treating Glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,503,510 | September 1, 2019 | June 30, 2024 | PLATANIAS, LEONIDAS C. | reporter.nih.gov |
| Novel Small Molecule Anti-Inflammatory Eye Drops for Ocular Graft Versus Host Disease | NIH | National Eye Institute | 2021 to 2022 | $1,499,999 | February 1, 2021 | August 31, 2024 | DING, JINDONG | reporter.nih.gov |
| Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,496,161 | April 1, 2019 | March 31, 2024 | KOONG, ALBERT | reporter.nih.gov |
| A RIPK2-Targeting Apoptosis-Inducing Small Molecule for the Treatment of Glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,492,646 | June 1, 2019 | March 31, 2024 | LAIRSON, LUKE LEE | reporter.nih.gov |
| Mechanisms of enhancer regulation in leukemia | NIH | National Cancer Institute | 2021 to 2023 | $1,487,277 | January 1, 2019 | December 31, 2023 | AIFANTIS, IANNIS | reporter.nih.gov |
| Predictive and systems modeling of exosome cargo | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,483,018 | January 1, 2019 | December 31, 2023 | DAVIS, MICHAEL E | reporter.nih.gov |
| Osteoclast modulatory biomaterials for skull regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $1,475,710 | August 1, 2020 | July 31, 2025 | LEE, JUSTINE CHIA | reporter.nih.gov |
| Designing cell-instructive hydrogels to understand and exploit mechanobiology | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,473,308 | September 1, 2020 | July 31, 2025 | CALIARI, STEVEN | reporter.nih.gov |
| "Establishing Pathways for Endothelial Support of Bone Formation with SLIT3" | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,465,497 | April 1, 2020 | February 28, 2025 | GREENBLATT, MATTHEW BLAKE | reporter.nih.gov |
| Driver Genes for Engineered Rotator Cuff Development | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,459,537 | March 15, 2019 | August 31, 2025 | LITTLE, DIANNE | reporter.nih.gov |
| Decoding innate immune signaling in normal and myelodysplastic hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,453,441 | January 10, 2017 | December 31, 2022 | STARCZYNOWSKI, DANIEL | reporter.nih.gov |
| Targeted Inhibition in Leukemia | NIH | National Cancer Institute | 2021 to 2023 | $1,448,596 | July 8, 2020 | June 30, 2025 | NASSAR, NICOLAS | reporter.nih.gov |
| Cell adhesion and cytoskeletal dynamics in the skin | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,438,349 | December 1, 1980 | August 31, 2023 | FUCHS, ELAINE | reporter.nih.gov |
| The Allogeneic Human Mesenchymal Stem Cell (MSCs) injection in Patients with Hypoplastic Left Heart Sydrome: A Phase IIb Clinical Trial (ELPIS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,435,351 | September 15, 2020 | August 31, 2025 | LAI, DEJIAN | reporter.nih.gov |
| Human Acute Myeloid Leukemia Stem Cells | NIH | National Cancer Institute | 2021 to 2024 | $1,433,586 | July 7, 2020 | June 30, 2025 | MAJETI, RAVINDRA | reporter.nih.gov |
| Alzheimer's disease-replicated brain microphysiological system to model AD physiopathology and its influenceon gliovasculature and immune system | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,423,803 | February 1, 2021 | January 31, 2026 | YUN, YEOHEUNG | reporter.nih.gov |
| pathQTL: Integrative Multi-Omics Causal Inference of Molecular Mechanisms Leading to Neuropsychiatric Illness | NIH | National Institute of Mental Health | 2021 to 2023 | $1,412,584 | December 10, 2018 | November 30, 2023 | STEIN, JASON LOUIS | reporter.nih.gov |
| Understanding stem cell heterogeneity and niche function in intestinal regeneration after irradiation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,404,650 | September 1, 2023 | August 31, 2024 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| Defining and targeting a novel pathway for central nervous system leptomeningeal metastasis | NIH | National Cancer Institute | 2021 to 2024 | $1,400,663 | January 6, 2020 | December 31, 2025 | SIPKINS, DOROTHY A | reporter.nih.gov |
| Maternal obesity and neonatal innate immunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $1,397,637 | September 24, 2018 | August 31, 2025 | MESSAOUDI, ILHEM | reporter.nih.gov |
| SON-mediated RNA splicing in glioblastoma | NIH | National Cancer Institute | 2021 to 2024 | $1,396,874 | July 1, 2020 | June 30, 2025 | AHN, ERIN EUN-YOUNG | reporter.nih.gov |
| Rejuvenating aged bone regeneration by innovative nanomaterials-mediated drug delivery | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $1,394,310 | July 1, 2020 | April 30, 2026 | SUN, HONGLI | reporter.nih.gov |
| The aging stem cell niche | NIH | National Institute on Aging | 2021 to 2024 | $1,389,900 | September 30, 2020 | April 30, 2026 | HUBBARD, E. JANE ALBERT | reporter.nih.gov |
| Vascular mural cells in the development of the blood brain barrier | NIH | National Institute of Mental Health | 2023 | $1,388,925 | September 1, 2023 | August 31, 2026 | CROUCH, ELIZABETH ERIN | reporter.nih.gov |
| Defining the role of TCAB1 and its phase separation in telomerase assembly. | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,383,810 | September 1, 2021 | July 31, 2025 | SCHMIDT, JENS CHRISTOPHER | reporter.nih.gov |
| Identifying Predictors of Poor Health-Related Quality-of-life among Pediatric Hematopoietic Stem Cell Donors | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,383,204 | January 6, 2018 | December 31, 2024 | SWITZER, GALEN E. | reporter.nih.gov |
| Distinct contributions of mesenchymal cell niches in the therapeutic potential of the hedgehog pathway in triple negative breast cancer | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,379,794 | August 1, 2020 | July 31, 2025 | DOMENECH, MARIBELLA | reporter.nih.gov |
| NAD+ Pathway Signaling in Glioblastoma Tumor Growth and Therapy Resistance | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,377,703 | July 1, 2019 | June 30, 2025 | KIM, ALBERT HONG-JAE | reporter.nih.gov |
| Molecular targeting of erythroid progenitor cells in normal and disordered human erythropoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,375,136 | January 15, 2019 | December 31, 2023 | BLANC, LIONEL | reporter.nih.gov |
| Regenerative Lipid Mediators for the Management of Severe Burn Wounds | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,367,499 | April 20, 2020 | February 28, 2026 | HONG, SONG | reporter.nih.gov |
| Sliding hydrogels for accelerating cartilage regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,364,113 | September 1, 2019 | July 31, 2025 | YANG, FAN | reporter.nih.gov |
| The role and mechanism of METTL3/METTL14-mediated RNA modification in the pathogenesis and drug-resistance of AML | NIH | National Cancer Institute | 2021 to 2023 | $1,361,506 | February 1, 2019 | January 31, 2024 | CHEN, JIANJUN | reporter.nih.gov |
| Developing a SMART scaffold for bladder augmentation | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2022 | $1,351,330 | August 9, 2019 | November 30, 2024 | AMEER, GUILLERMO ANTONIO | reporter.nih.gov |
| Bayesian Methods for Complex Precision Biotherapy Trials in Oncology | NIH | National Cancer Institute | 2021 to 2024 | $1,350,553 | September 15, 2021 | August 31, 2025 | THALL, PETER F | reporter.nih.gov |
| A novel approach for treating diabetes using pulsed focused ultrasound and intra-arterial delivery of mesenchymal stem cell based therapies directly into the pancreas | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,349,935 | September 1, 2019 | May 31, 2024 | THAKOR, AVNESH SINH | reporter.nih.gov |
| Cellular and functional impact of SAMD9L mutations on hematopoiesis and myelodysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,346,250 | January 1, 2019 | December 31, 2024 | KLCO, JEFFERY M | reporter.nih.gov |
| Stem cell-based tissue engineering for myotendinous junction modeling and repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,344,008 | April 1, 2020 | January 31, 2026 | SUZUKI, MASATOSHI | reporter.nih.gov |
| The influence of common genetic variation on brain overgrowth pathways | NIH | National Institute of Mental Health | 2021 to 2023 | $1,336,156 | August 1, 2019 | May 31, 2025 | STEIN, JASON LOUIS | reporter.nih.gov |
| Enhancement of stem cell regenerative properties by hydrogen sulfide: a novel wound dressing to augment stem cell therapies | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,332,634 | September 15, 2020 | August 31, 2025 | TOLIVER-KINSKY, TRACY E | reporter.nih.gov |
| Regulatory Landscape of the Aging Human Ovary | NIH | National Institute on Aging | 2021 to 2024 | $1,329,912 | September 30, 2020 | May 31, 2025 | WILLIAMS, ZEV | reporter.nih.gov |
| Aging and dysfunction of progenitor niches: Role of Del-1 | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $1,326,269 | January 1, 2020 | December 31, 2025 | HAJISHENGALLIS, GEORGIOS | reporter.nih.gov |
| Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and Therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,323,906 | August 15, 2018 | June 30, 2024 | KUO, CALVIN J | reporter.nih.gov |
| Stem cells for craniofacial bone repair and regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $1,322,241 | June 30, 2021 | May 31, 2025 | HSU, WEI | reporter.nih.gov |
| Endothelial progenitor cells and neurovascular injury in the aging brain | NIH | National Institute on Aging | 2021 to 2023 | $1,321,673 | September 1, 2019 | August 1, 2023 | NATION, DANIEL A | reporter.nih.gov |
| The role and regulation of Hippo pathway in sarcomagenesis | NIH | National Cancer Institute | 2021 to 2023 | $1,314,226 | March 1, 2019 | February 29, 2024 | EISINGER, TZIPORA SARAH KARIN | reporter.nih.gov |
| A cutaneous gene therapy for cocaine abuse and alcohol co-abuse | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,312,200 | September 30, 2019 | July 31, 2025 | XU, MING | reporter.nih.gov |
| Specialized cell cycles in early erythropoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,308,027 | September 15, 2019 | June 30, 2025 | SOCOLOVSKY, MERAV | reporter.nih.gov |
| Identification of therapeutic targets for leukemia stem cells in AML-iPSC models | NIH | National Cancer Institute | 2021 to 2022 | $1,306,690 | March 1, 2018 | February 28, 2023 | PAPAPETROU, EIRINI | reporter.nih.gov |
| Zika Virus Capsid Protein Mediated Blockage of host microRNA machinery | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,302,099 | May 1, 2019 | February 28, 2025 | ZHAO, ZHEN | reporter.nih.gov |
| Hypopituitarism: role of PROP1 and retinoic acid signaling in regulation of pituitary stem cell differentiation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,296,374 | March 4, 2019 | February 29, 2024 | CAMPER, SALLY A. | reporter.nih.gov |
| Obesity-induced mesenchymal stem cell senescence | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,283,174 | December 27, 2018 | November 30, 2024 | LERMAN, LILACH O | reporter.nih.gov |
| Tumor-Suppressive Functions and Molecular Regulation of LRIG1 in Prostate Cancer and CRPC | NIH | National Cancer Institute | 2021 to 2023 | $1,283,103 | March 1, 2019 | August 31, 2024 | TANG, DEAN G. | reporter.nih.gov |
| Targeting Drug-Resistant Cancer Stem Cell Niches of Gastrointestinal Stromal Tumor | NIH | National Cancer Institute | 2021 to 2023 | $1,276,977 | June 1, 2019 | May 31, 2024 | SICKLICK, JASON KEITH | reporter.nih.gov |
| The Human Distal Airway Aging Project | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,276,622 | January 1, 2019 | December 31, 2023 | SHAYKHIEV, RENAT | reporter.nih.gov |
| Skeletal Muscle Stem Cells Derived from Teratomas | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,274,254 | May 1, 2019 | April 30, 2024 | KYBA, MICHAEL | reporter.nih.gov |
| Mesodermal Commitment of the Definitive Hematopoietic Program | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,268,334 | January 15, 2021 | April 30, 2025 | STURGEON, CHRISTOPHER MICHAEL | reporter.nih.gov |
| Redefining mesenchymal stem cells: using their cellular and molecular phenotypes to determine their regenerative and therapeutic properties | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $1,262,179 | September 1, 2019 | August 31, 2025 | KAIGLER, DARNELL | reporter.nih.gov |
| Macrocyclic Peptidyl Inhibitors of NEMO-IKK Interaction | NIH | National Cancer Institute | 2021 to 2023 | $1,247,018 | July 1, 2019 | June 30, 2026 | PEI, DEHUA | reporter.nih.gov |
| Analysis of epithelial heterogeneity in prostate development and cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,242,555 | April 1, 2019 | August 31, 2024 | SHEN, MICHAEL M. | reporter.nih.gov |
| Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,241,707 | June 11, 2018 | May 31, 2024 | AN, DONG SUNG | reporter.nih.gov |
| The Peripheral Nervous System: A Window into Krabbe Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,234,701 | February 1, 2019 | January 31, 2025 | SIM, FRASER JAMES | reporter.nih.gov |
| Single Cell Profiling To Define Biomarkers Of Photoreceptor Dysfunction After Gene Editing Within PSC-Derived Organoids | NIH | National Eye Institute | 2021 to 2022 | $1,223,974 | September 5, 2018 | June 30, 2024 | SAHA, KRISHANU | reporter.nih.gov |
| Defining the intestinal stem cell niche during organoid development into a functional human intestine | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,222,000 | September 1, 2014 | August 31, 2024 | HELMRATH, MICHAEL A. | reporter.nih.gov |
| Progenitor cell based therapy to mitigate radiation induced gastro intestinal syndrome- supplement | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,220,595 | March 7, 2018 | February 29, 2024 | SAHA, SUBHRAJIT | reporter.nih.gov |
| Niche support of human intestinal stem cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,213,203 | September 1, 2014 | August 31, 2024 | SPENCE, JASON | reporter.nih.gov |
| Progenitor Regulation Underlying Cortical Interneuron Specification | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,212,394 | July 1, 2018 | March 31, 2024 | ROSS, MARGARET ELIZABETH | reporter.nih.gov |
| Stromal cell therapy as a treatment against Gastrointestinal Acute Radiation Syndrome (GI-ARS) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,193,484 | March 9, 2018 | February 29, 2024 | GUHA, CHANDAN | reporter.nih.gov |
| Utilizing beige fat to improve muscle function after rotator cuff repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,192,600 | September 1, 2018 | June 30, 2024 | FEELEY, BRIAN | reporter.nih.gov |
| Regulation of Human Epidermal Tumorigenesis by the mRNA Degradation Pathway | NIH | National Cancer Institute | 2021 to 2023 | $1,183,479 | December 1, 2018 | November 30, 2024 | SEN, GEORGE L | reporter.nih.gov |
| Hematopoietic Stem and Progenitor Cell Dysfunction is an Underlying Mechanism of Injury-Inuced Immunosuppression | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,181,248 | September 5, 2019 | June 30, 2025 | TURNBULL, ISAIAH R | reporter.nih.gov |
| The role of Abelson interactor 1 (Abi-1) in hematopoietic stem cell self-renewal and malignant transformation | NIH | National Cancer Institute | 2021 to 2023 | $1,172,540 | July 24, 2019 | June 30, 2025 | DUBIELECKA-SZCZERBA, PATRYCJA MARTA | reporter.nih.gov |
| Targeting trained immunity and Th1/Th17 axis with combination adjuvants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,167,749 | July 26, 2021 | September 1, 2022 | KHADER, SHABAANA A. | reporter.nih.gov |
| Pathobiological mechanisms of persistent post-COVID19 olfactory dysfunction | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2022 | $1,164,667 | August 15, 2019 | June 30, 2024 | GOLDSTEIN, BRADLEY J | reporter.nih.gov |
| Electrical Stimulation of Human CPCs | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,162,500 | February 10, 2020 | February 28, 2026 | MAXWELL, JOSHUA THOMAS | reporter.nih.gov |
| Targeting Lipid Unsaturation in Ovarian Cancer Stem Cells | NIH | National Cancer Institute | 2021 to 2022 | $1,158,147 | August 1, 2018 | July 31, 2024 | MATEI, DANIELA E | reporter.nih.gov |
| The impact of HIV driven T cell immune activation in angiogenic CD8 T cell function: the role of PAR1 signaling | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,157,094 | May 23, 2019 | February 28, 2025 | CATALFAMO, MARTA L. | reporter.nih.gov |
| Revealing muscle stem cell heterogeneity in mice and humans through deep single-cell analysis | NIH | National Institute on Aging | 2021 to 2022 | $1,150,610 | September 30, 2018 | May 31, 2024 | COSGROVE, BENJAMIN DAVID | reporter.nih.gov |
| Magnetic Steering and Longitudinal Visualization of Stem Cells for Trabecular Meshwork Therapy in Glaucoma | NIH | National Eye Institute | 2021 to 2022 | $1,149,852 | July 1, 2019 | June 30, 2024 | ETHIER, C ROSS | reporter.nih.gov |
| Deciphering the role of Lmod2 in cardiac muscle and in dilated cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,147,217 | April 1, 2015 | January 31, 2025 | GREGORIO, CAROL C | reporter.nih.gov |
| The Phase I/II Randomized, Prospective, Double-blinded, Sham-controlled Cross-over Study of Intravitreal Autologous Bone Marrow CD34+ Stem Cell Therapy for Retinal Vein Occlusion | NIH | National Eye Institute | 2021 to 2022 | $1,146,789 | June 15, 2018 | May 31, 2026 | PARK, SUSANNA S | reporter.nih.gov |
| Modeling alcohol toxicity in human hepatocytes | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $1,144,125 | September 5, 2019 | June 30, 2025 | DE JONG, YPE PETER | reporter.nih.gov |
| Perturbation of Host DNA Replication and Cell Cycle Progression by Zika Virus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,136,450 | July 1, 2019 | June 30, 2026 | TANG, HENGLI | reporter.nih.gov |
| The histone demethylase JMJD1C in human Acute Myeloid Leukemia | NIH | National Cancer Institute | 2021 to 2023 | $1,135,709 | May 16, 2019 | April 30, 2024 | ZHU, NAN | reporter.nih.gov |
| The Role of DPP in Dental Pulp Stem Cells and its Potential in Tissue Regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $1,135,491 | April 1, 2019 | September 30, 2025 | GEORGE, ANNE | reporter.nih.gov |
| IRS function in breast cancer progression | NIH | National Cancer Institute | 2021 to 2023 | $1,134,142 | July 1, 2019 | June 30, 2024 | SHAW, LESLIE M | reporter.nih.gov |
| Tissue Tension, RANK and Breast Cancer Risk | NIH | National Cancer Institute | 2021 to 2022 | $1,132,981 | February 9, 2018 | January 31, 2024 | WEAVER, VALERIE MARIE | reporter.nih.gov |
| The role of lamin B1 in normal and myelodysplastic hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $1,129,384 | July 1, 2023 | May 31, 2027 | DOULATOV, SERGEI | reporter.nih.gov |
| Gestational Iron Deficiency disrupts neural patterning in the embryo | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,128,846 | September 1, 2018 | June 30, 2025 | MAYER-PROSCHEL, MARGOT | reporter.nih.gov |
| Combination treatment of ischemic stroke with perlecan DV and neural stem cells | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,115,919 | December 15, 2018 | May 31, 2023 | LEE, JEAN-PYO | reporter.nih.gov |
| Interaction between Tissue Factor, Junctional Adhesion Molecule-A, and Integrin B1 to drive self-renewal in glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,114,528 | April 1, 2020 | January 31, 2026 | HORBINSKI, CRAIG MICHAEL | reporter.nih.gov |
| Engineered and Encapsulated Stem Cells for Resected Brain Tumors | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,113,859 | March 1, 2019 | February 29, 2024 | SHAH, KHALID A | reporter.nih.gov |
| Dissect governing factors for tumor stem cell dormancy in biomimetic vascular/GBM model | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,112,664 | August 1, 2018 | July 31, 2023 | ZOU, HONGYAN JENNY | reporter.nih.gov |
| Correction of diabetic retinopathy by mitochondrial transfer | NIH | National Eye Institute | 2023 to 2024 | $1,109,489 | July 1, 2023 | May 3, 2024 | PROSHLYAKOV, DENIS A | reporter.nih.gov |
| PRECLINICAL EVALUATION OF NANOPARTICULATE MINERALIZED COLLAGEN GLYCOSAMINOGLYCAN MATERIALS IN CALVARIAL REGENERATION | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $1,107,545 | May 1, 2019 | April 30, 2025 | LEE, JUSTINE CHIA | reporter.nih.gov |
| Role of Shp2 in FLT3-ITD induced leukemogenesis | NIH | National Cancer Institute | 2021 to 2023 | $1,107,227 | April 1, 2011 | January 31, 2025 | KAPUR, REUBEN | reporter.nih.gov |
| Organoid modeling to determine and reverse age-related epigenetic changes contributing to risk of colorectal cancer | NIH | National Cancer Institute | 2021 to 2024 | $1,104,519 | July 1, 2019 | December 31, 2024 | BAYLIN, STEPHEN B. | reporter.nih.gov |
| Prevention of post-therapy breast cancer metastasis | NIH | National Cancer Institute | 2021 to 2023 | $1,102,143 | April 12, 2019 | March 31, 2026 | WANG, XINHUI | reporter.nih.gov |
| Clonal Reconstruction and Targeting of the Correa Sequence | NIH | National Cancer Institute | 2021 to 2023 | $1,101,644 | July 19, 2019 | December 31, 2024 | MCKEON, FRANK D. | reporter.nih.gov |
| Molecular mechanisms of SCLC initiation and detection in mice and humans | NIH | National Cancer Institute | 2021 to 2022 | $1,100,684 | September 19, 2018 | August 31, 2024 | KRASNOW, MARK A | reporter.nih.gov |
| Targeting a Novel Hematopoietic Stem Cell Population in Non-Human Primates for Effective and Sustained Gene Therapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,096,475 | November 10, 2017 | March 31, 2022 | KIEM, HANS-PETER | reporter.nih.gov |
| Optimization of small molecule integrin activators to enhance cord blood transplant | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,094,056 | February 15, 2022 | January 31, 2025 | VANDERSLICE, PETER | reporter.nih.gov |
| Prebiotics to Optimize the Microbiota and Improve Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,086,750 | July 1, 2020 | June 1, 2024 | SUNG, ANTHONY | reporter.nih.gov |
| Biodegradable Matrices with Structural and Physical Cues for Interface Engineering | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2024 | $1,084,031 | September 17, 2020 | June 30, 2026 | NUKAVARAPU, SYAM | reporter.nih.gov |
| Elucidating and targeting subtype-specific driver in pancreatic cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,083,360 | April 1, 2019 | March 31, 2024 | YING, HAOQIANG | reporter.nih.gov |
| Estrogen Receptor Signaling in Hematopoietic Stem Cell Proliferation and Mobilization | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,082,400 | August 20, 2020 | May 31, 2025 | OGURO, HIDEYUKI | reporter.nih.gov |
| Engineered Anisotropic and Vascularized Human Cardiac Patch | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,081,932 | March 26, 2021 | June 30, 2025 | ZHAO, FENG | reporter.nih.gov |
| Gene Delivery Nanoparticles to Treat Glioblastoma | NIH | National Cancer Institute | 2021 to 2023 | $1,080,169 | December 16, 2018 | November 30, 2024 | GREEN, JORDAN | reporter.nih.gov |
| Posttranscriptional control of epidermal progenitors senescence | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,079,289 | March 1, 2019 | August 31, 2024 | MANDINOVA, ANNA | reporter.nih.gov |
| Bone Marrow Spatial Transcriptomics to Enhance In Vitro Platelet Production | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,076,177 | August 1, 2021 | July 31, 2025 | CANTOR, ALAN B. | reporter.nih.gov |
| DNA hydroxymethylation and Tet-enzymes in the control of the skin development and hair growth | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,074,480 | August 1, 2019 | June 30, 2024 | BOTCHKAREV, VLADIMIR A | reporter.nih.gov |
| Hedgehog/Gli1-targeted therapies to overcome ovarian cancer chemoresistance and disease recurrence | NIH | National Cancer Institute | 2021 to 2023 | $1,069,550 | February 15, 2018 | July 31, 2025 | PALLE, KOMARAIAH | reporter.nih.gov |
| Role of lincRNAs in HSC function and leukemogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,067,858 | January 15, 2019 | December 31, 2023 | XU, MINGJIANG | reporter.nih.gov |
| Defining Mechanisms of Transformation Driven By the Zinc Finger Transcription Factor PLAGL2 in the Intestinal Epithelium | NIH | National Cancer Institute | 2021 to 2023 | $1,066,433 | April 1, 2019 | March 31, 2025 | RUBIN, DEBORAH C. | reporter.nih.gov |
| MINE-MS for horizontal bone loss treatment | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $1,063,812 | March 5, 2021 | August 31, 2023 | LIU, XIAOHUA | reporter.nih.gov |
| A novel role of fascin in cancer metastasis | NIH | National Cancer Institute | 2021 to 2023 | $1,063,661 | December 4, 2018 | November 30, 2024 | YANG, SHENGYU | reporter.nih.gov |
| Tet2 regulation and function in glioma cell phenotype reprogramming | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,060,500 | August 1, 2019 | May 31, 2025 | LATERRA, JOHN J | reporter.nih.gov |
| Targeting CD133 for imaging and therapy in prostate cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,060,004 | July 1, 2021 | June 30, 2025 | LEBEAU, AARON MATTHEW | reporter.nih.gov |
| The Role of FoxQ1 in Breast Cancer Chemoprevention by Allium Constituents - R01CA219180 | NIH | National Cancer Institute | 2021 to 2023 | $1,059,662 | April 1, 2019 | March 31, 2025 | SINGH, SHIVENDRA | reporter.nih.gov |
| IL-27 as a potential immunotherapeutic for cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,056,276 | July 1, 2019 | June 30, 2025 | BASU, SUJIT | reporter.nih.gov |
| Transcriptional response to signaling during hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,056,094 | January 15, 2019 | December 31, 2023 | ZON, LEONARD IRA | reporter.nih.gov |
| The role of breast stem cells in breast cancer etiology and risk prediction | NIH | National Cancer Institute | 2021 to 2023 | $1,053,765 | December 6, 2019 | November 30, 2024 | YAGHJYAN, LUSINE | reporter.nih.gov |
| Roadmap 2.0: A randomized controlled trial using a technology-mediated platform in family caregivers of BMT patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,053,000 | April 1, 2019 | March 31, 2025 | CHOI, SUNG WON | reporter.nih.gov |
| Investigation of a Novel Cancer Stem Cell Population in Ependymoma. | NIH | National Cancer Institute | 2021 to 2023 | $1,052,890 | April 1, 2019 | December 31, 2024 | FOREMAN, NICHOLAS K | reporter.nih.gov |
| Endocytic Trafficking of ADCs in GBM cancer stem-like cells | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,051,314 | April 1, 2019 | March 31, 2024 | GLADSON, CANDECE L | reporter.nih.gov |
| Targeting PGC-1a for the treatment of sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,050,000 | July 1, 2022 | May 31, 2026 | CUI, SHUAIYING | reporter.nih.gov |
| Tissue-Regulated Lineage-Specific Splicing in Glioblastoma Pathogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,046,925 | September 1, 2020 | May 31, 2025 | WILLEY, CHRISTOPHER D | reporter.nih.gov |
| Microenvironmental Regulation of Leukemia Stem Cells | NIH | National Cancer Institute | 2021 to 2023 | $1,043,956 | July 1, 2013 | May 31, 2024 | BHATIA, RAVI | reporter.nih.gov |
| Cell Therapy Program with Scale-up cGMP Manufacturing of Human Corneal Stromal Stem Cells | NIH | National Eye Institute | 2023 to 2024 | $1,041,848 | September 1, 2023 | June 30, 2025 | YAM, HIN FAI | reporter.nih.gov |
| A Genetically Engineered Human Fetal Liver Niche as a Novel Platform for Biomanufacturing of Hematopoietic Stem Cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,037,088 | July 1, 2019 | June 30, 2025 | EBRAHIMKHANI, MO REZA | reporter.nih.gov |
| Role of purine metabolism in chemoresistance | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,036,875 | September 1, 2019 | June 30, 2025 | AHMED, ATIQUE U. | reporter.nih.gov |
| Discovery of small molecule promoters of cardiomyocyte proliferation to restore cardiac performance in disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,035,375 | June 17, 2019 | October 31, 2023 | COLAS, ALEXANDRE ROMAIN | reporter.nih.gov |
| Promoting Muscle Regeneration through Adipose Signaling | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,035,159 | July 22, 2019 | June 30, 2025 | MEYER, GRETCHEN A | reporter.nih.gov |
| Enhancing Venetoclax Activity in Chemoresistant Acute Myeloid Leukemia | NIH | National Cancer Institute | 2021 to 2024 | $1,034,244 | March 1, 2020 | August 31, 2025 | GARCIA, JACQUELINE SUEN | reporter.nih.gov |
| Epigenetic drivers of cancer progression | NIH | National Cancer Institute | 2021 to 2023 | $1,032,037 | May 1, 1991 | June 30, 2025 | FEINBERG, ANDREW P. | reporter.nih.gov |
| Non-canonical WNT signaling in emphysema and lung regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,027,860 | February 1, 2019 | April 30, 2025 | KOENIGSHOFF, MELANIE | reporter.nih.gov |
| Investigations of menin function in Ewing sarcoma | NIH | National Cancer Institute | 2021 to 2022 | $1,026,275 | June 1, 2020 | September 30, 2023 | LAWLOR, ELIZABETH R | reporter.nih.gov |
| Echogenic polymersomes for triggered contents release | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,024,521 | September 5, 2015 | November 15, 2024 | MALLIK, SANKU | reporter.nih.gov |
| Novel Radioimmunotherapy Strategies for Prostate Cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,020,311 | July 1, 2019 | June 30, 2025 | LEBEAU, AARON MATTHEW | reporter.nih.gov |
| Strengthening epidermal defenses for the prevention of HPV infection and replication | NIH | National Cancer Institute | 2021 to 2023 | $1,017,436 | December 4, 2018 | November 30, 2023 | WELLS, SUSANNE I | reporter.nih.gov |
| The Function of EGFL6 in Ovarian Cancer Cell Biology, Tumor Initiation, and Therapy | NIH | National Cancer Institute | 2021 to 2023 | $1,016,872 | December 1, 2018 | November 30, 2023 | BUCKANOVICH, RONALD J | reporter.nih.gov |
| GENETIC HETEROGENEITY AMONG HUMAN SOMATIC CELLS AND ITS ACCUMULATION WITH AGE | NIH | National Institute on Aging | 2021 to 2024 | $1,014,750 | August 1, 2020 | April 30, 2026 | HSIEH, CHIH-LIN | reporter.nih.gov |
| Towards Understanding Molecular Mechanisms of Human Hematopoietic Stem Cells' Quiescence | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,014,000 | February 15, 2022 | January 31, 2026 | GHAFFARI, SAGHI | reporter.nih.gov |
| A Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients. | NIH | National Cancer Institute | 2021 to 2024 | $1,011,996 | September 3, 2020 | August 31, 2025 | AMONOO, HERMIONI L. | reporter.nih.gov |
| Extending the scope of PLX-R18 for H-ARS: efficacy in special populations and DEARE | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,010,588 | March 8, 2018 | February 29, 2024 | ORSCHELL, CHRISTIE M | reporter.nih.gov |
| Single-cell multi-omic analysis of opioid-mediated HIV disease pathogenesis | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,009,425 | September 30, 2023 | August 31, 2025 | COLLINS, KATHLEEN L. | reporter.nih.gov |
| DNA Methylation Inhibitor Therapy for Testicular Cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,005,756 | May 1, 2018 | April 30, 2024 | SPINELLA, MICHAEL J | reporter.nih.gov |
| Hematopoietic stem cells overcome treatment resistance to adoptive cellular therapy against malignant gliomas | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,000,782 | September 1, 2019 | June 30, 2024 | FLORES, CATHERINE T | reporter.nih.gov |
| Transdermal estrogen for the treatment of bone loss in women with anorexia nervosa | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $997,598 | September 1, 2019 | June 30, 2025 | FAZELI, POUNEH KHADEJEH | reporter.nih.gov |
| Functional Dissection of Alzheimer's Disease Networks in Drosophila: from Association to Causal Modulators of Age-Dependent Neurodegeration | NIH | National Institute on Aging | 2021 | $994,786 | September 15, 2017 | May 31, 2022 | BOTAS, JUAN | reporter.nih.gov |
| Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing | NIH | National Heart, Lung, and Blood Institute | 2021 | $993,756 | September 1, 2019 | May 31, 2023 | GEISSE, NICHOLAS ANDREW | reporter.nih.gov |
| Aged tissue environments as drivers of oncogenic adaptation in hematopoiesis | NIH | National Institute on Aging | 2021 to 2024 | $991,916 | January 1, 2020 | November 30, 2025 | DEGREGORI, JAMES V | reporter.nih.gov |
| Multi-layered Control of the Exit from Stemness | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $990,885 | February 1, 2019 | January 31, 2024 | LEE, CHENG-YU | reporter.nih.gov |
| Mechanisms controlling early human lung development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $972,953 | August 1, 2018 | May 31, 2024 | AL-ALAM, DENISE | reporter.nih.gov |
| Pericyte reprogramming in fibrosis | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2024 | $970,522 | August 1, 2023 | July 31, 2025 | GONZALEZ, ANJELICA | reporter.nih.gov |
| VRC: Engineered extracellular vesicles for mild TBI-induced retinal injury | NIH | National Eye Institute | 2022 to 2024 | $967,616 | September 1, 2022 | May 31, 2026 | ROTH, STEVEN | reporter.nih.gov |
| A bio-engineered hepatic niche for ex vivo expansion of HSCs | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $959,400 | July 16, 2021 | June 30, 2025 | PAJCINI, KOSTANDIN | reporter.nih.gov |
| Targeting LIF/LIFR in pancreatic cancer | NIH | National Cancer Institute | 2021 | $956,072 | April 2, 2019 | April 30, 2023 | NAIR, HAREESH BABU | reporter.nih.gov |
| Targeting Glioblastoma Stem Cells | NIH | National Cancer Institute | 2024 | $954,000 | September 1, 2024 | August 31, 2031 | RICH, JEREMY N | reporter.nih.gov |
| Regulation of the Intestinal Stem Cells During Regeneration | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $949,042 | September 1, 2019 | May 31, 2024 | BREAULT, DAVID T | reporter.nih.gov |
| KDM1A inhibitors as novel therapeutics for glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $947,506 | May 1, 2019 | February 28, 2025 | SAREDDY, GANGADHARA R | reporter.nih.gov |
| Glycosylation-dependent mechanisms regulating ovarian tumor cell phenotype | NIH | National Cancer Institute | 2021 to 2023 | $939,559 | May 15, 2014 | March 31, 2025 | BELLIS, SUSAN L | reporter.nih.gov |
| MYCT1 as a moderator for signaling between human HSC and their niche | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $936,000 | April 1, 2022 | February 28, 2026 | MIKKOLA, HANNA KATRI ANNIKKI | reporter.nih.gov |
| A small molecule integrin activator to enhance cord blood transplant | NIH | National Heart, Lung, and Blood Institute | 2021 | $928,941 | September 1, 2016 | February 28, 2023 | VANDERSLICE, PETER | reporter.nih.gov |
| Tissue Regeneration by Engineered Extracellular Vesicles | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $920,284 | September 20, 2019 | May 31, 2024 | BRYERS, JAMES D. | reporter.nih.gov |
| Gut microbiome communication with the bone marrow regulates intestinal inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $918,980 | March 16, 2020 | June 4, 2024 | BURGESS, STACEY L | reporter.nih.gov |
| Therapeutic Targeting of Malignant Glioma Stem Cells | NIH | National Cancer Institute | 2021 | $916,993 | August 13, 2015 | July 31, 2022 | LESNIAK, MACIEJ S | reporter.nih.gov |
| Targeting the Unfolded Protein Response in Leukemia Biology and Chemotherapy Resistance | NIH | National Cancer Institute | 2021 to 2023 | $916,031 | May 7, 2019 | April 30, 2024 | SYKES, STEPHEN MATTHEW | reporter.nih.gov |
| Dysregulation of the Core Binding Factor Complex Inhibits Differentiation and Drives Group 4 Medulloblastoma | NIH | National Cancer Institute | 2021 to 2022 | $906,063 | April 4, 2011 | September 2, 2022 | WECHSLER-REYA, ROBERT J. | reporter.nih.gov |
| Dynamic Complexity of Brain Tumor Stem Cells (R35CA197718) | NIH | National Cancer Institute | 2021 | $904,608 | June 7, 2021 | August 31, 2023 | RICH, JEREMY N | reporter.nih.gov |
| Gamma delta T-cell immunotherapy for T-cell acute lymphoblastic leukemia | NIH | National Cancer Institute | 2021 to 2024 | $897,984 | April 1, 2020 | March 31, 2025 | RAIKAR, SUNIL SUDHIR | reporter.nih.gov |
| Role of Quaking gene in regulating the niche-independent stemness of glioma stem cells | NIH | National Cancer Institute | 2021 to 2022 | $890,670 | December 1, 2017 | November 30, 2023 | HU, JIAN | reporter.nih.gov |
| The role of GPR133 in glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $889,716 | August 1, 2018 | April 30, 2024 | PLACANTONAKIS, DIMITRIS G. | reporter.nih.gov |
| Defining LncRNA Function in normal and Shwachman Diamond Syndrome Myelopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $882,500 | January 15, 2019 | December 31, 2023 | NOVINA, CARL D | reporter.nih.gov |
| Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation | NIH | National Cancer Institute | 2021 to 2022 | $882,452 | August 9, 2018 | July 31, 2023 | EL-JAWAHRI, AREEJ | reporter.nih.gov |
| Elucidating Human Leukemia and T Cell Interactions within the Tumor Microenvironment | NIH | National Cancer Institute | 2021 to 2024 | $870,112 | April 1, 2021 | March 31, 2026 | BACHIREDDY, PAVAN | reporter.nih.gov |
| eHealth Supported Mindfulness-based Music Therapy Intervention (eMBMT) in Hemopoietic Stem Cell Transplant Patients | NIH | National Cancer Institute | 2022 to 2023 | $865,658 | September 9, 2022 | May 31, 2025 | PENEDO, FRANK J | reporter.nih.gov |
| Re-engineering a human 3D liver tissue model for non-alcoholic fatty liver disease for drug screening | NIH | National Center for Advancing Translational Sciences | 2022 to 2023 | $865,037 | July 1, 2022 | May 31, 2024 | MIEDEL, MARK T. | reporter.nih.gov |
| Targeting protein acetylation as a therapeutic approach for MDS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $865,000 | March 3, 2018 | February 29, 2024 | LI, LING | reporter.nih.gov |
| A Treatment Paradigm for Femoracetabular Impingement (FAI) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $849,426 | June 1, 2020 | May 31, 2023 | ESTES, BRADLEY T | reporter.nih.gov |
| Targeting Glioblastoma Stem Cells through Epigenetic Reprogramming | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $845,323 | June 15, 2018 | March 31, 2024 | FAN, XING | reporter.nih.gov |
| Hydrogels for hMSC delivery & engraftment | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $844,435 | August 1, 2012 | July 31, 2024 | GARCIA, ANDRES J | reporter.nih.gov |
| The role of the ErbB4 and ErbB3 neuregulin receptors in intestinal epithelial regeneration | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $843,062 | July 1, 2013 | May 31, 2025 | FREY, MARK R | reporter.nih.gov |
| GAS6-mediated alveolar bone regeneration | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2024 | $842,197 | August 1, 2022 | July 31, 2025 | DECKER, ANN MARIE | reporter.nih.gov |
| Programmable Synthetic Organelles Built from Disordered Proteins for Cellular Engineering | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2022 | $831,288 | September 15, 2019 | May 31, 2024 | GOOD, MATTHEW CHARLTON | reporter.nih.gov |
| Defining the signaling pathways that direct adult tissue stem cells to exit multipotency | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $825,000 | August 23, 2018 | July 31, 2023 | GUPTA, PIYUSH | reporter.nih.gov |
| Perfusable 3D human cardiac constructs for heart regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 | $824,083 | April 1, 2018 | February 28, 2023 | ZHENG, YING | reporter.nih.gov |
| Metabolic Control of Hair Follicle Stem Cell Homeostasis and Tumorigenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $823,700 | March 12, 2018 | February 29, 2024 | LOWRY, WILLIAM E | reporter.nih.gov |
| A novel sulforaphane cancer preventionmechanism | NIH | National Cancer Institute | 2021 to 2022 | $823,501 | February 15, 2018 | January 31, 2023 | ECKERT, RICHARD L. | reporter.nih.gov |
| MNSOD ACETYLATION PROMOTES CANCER STEM CELL PHENOTYPES IN BREAST CANCER | NIH | National Cancer Institute | 2021 to 2022 | $823,094 | August 14, 2018 | July 31, 2024 | BONINI, MARCELO G. | reporter.nih.gov |
| CRISPR-based transistors for high throughput multiplexed monitoring of CRISPR-based editing efficiency for Sickle cells disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $814,602 | January 7, 2022 | November 1, 2023 | ARAN, KIANA | reporter.nih.gov |
| Investigation of impaired neural stem cell activation in Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2023 | $813,190 | June 1, 2022 | July 31, 2023 | WEBB, ASHLEY E | reporter.nih.gov |
| Mesenchymal Stromal Cell Delivery through Cardiopulmonary Bypass in Pediatric Cardiac Surgery | NIH | National Heart, Lung, and Blood Institute | 2021 | $813,164 | May 21, 2019 | April 30, 2024 | ISHIBASHI, NOBUYUKI | reporter.nih.gov |
| Dual function of HSP70 in cytoprotection of tumor cells and generation of permissive microenvironment | NIH | National Cancer Institute | 2021 to 2023 | $812,348 | May 1, 2021 | June 30, 2023 | KORKAYA, HASAN | reporter.nih.gov |
| Developing miR-10b targeting for glioblastoma | NIH | National Cancer Institute | 2021 to 2022 | $809,591 | March 15, 2018 | February 29, 2024 | KRICHEVSKY, ANNA M. | reporter.nih.gov |
| An Enabling Technology for Human Cardiomyocyte Manufacturing | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $809,465 | June 1, 2022 | May 31, 2025 | LEI, YUGUO | reporter.nih.gov |
| (PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution | NIH | National Cancer Institute | 2021 to 2022 | $808,597 | September 1, 2017 | August 31, 2024 | GHOSH, MOUMITA | reporter.nih.gov |
| Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy | NIH | National Center for Advancing Translational Sciences | 2021 | $807,541 | September 1, 2020 | July 31, 2022 | KIM, DEOK-HO | reporter.nih.gov |
| A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS | NIH | National Center for Advancing Translational Sciences | 2021 | $800,773 | July 1, 2020 | May 31, 2022 | SVENDSEN, CLIVE NIELS | reporter.nih.gov |
| Mechanism and therapeutic potential of microglia regulation in glioblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $800,000 | September 1, 2022 | July 31, 2024 | CHEN, PEIWEN | reporter.nih.gov |
| Regulation of hematopoiesis by CUX1 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $798,096 | July 15, 2018 | June 30, 2023 | MCNERNEY, MEGAN | reporter.nih.gov |
| Administrative Supplement for Combining Experiments and Computer Simulation to Improve the Stem Cell Differentiation Process | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2022 | $795,817 | September 1, 2021 | August 31, 2023 | BOWLING, ALAN PAUL | reporter.nih.gov |
| CRISPR Editing of Primary Human Cells to Model and Correct Primary Immunodeficiency Mutations | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $794,940 | July 1, 2020 | June 30, 2025 | NGUYEN, DAVID-HUY NHU | reporter.nih.gov |
| A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease | NIH | National Center for Advancing Translational Sciences | 2021 | $791,956 | July 15, 2020 | June 30, 2022 | TAYLOR, D. LANSING | reporter.nih.gov |
| Multi-antigen-specific CAR T cells to treat acute myeloid leukemia | NIH | National Cancer Institute | 2021 to 2023 | $789,102 | September 1, 2020 | June 30, 2024 | JAMES, SCOTT E | reporter.nih.gov |
| Cell-specific nanocarrier with endocytic and endosomolytic activities for therapeutic genome editing | NIH | National Center for Advancing Translational Sciences | 2021 | $784,845 | August 22, 2019 | November 30, 2022 | LAM, KIT S | reporter.nih.gov |
| Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $782,684 | May 1, 2017 | April 30, 2022 | BREHM, MICHAEL ALLEN | reporter.nih.gov |
| Giving and receiving: A reciprocal support writing intervention to reduce symptoms during stem cell transplant | NIH | National Cancer Institute | 2021 | $782,416 | August 1, 2018 | June 30, 2023 | RINI, CHRISTINE | reporter.nih.gov |
| Pathobiologic Transcriptional Signatures of Pulmonary Complications in Pediatric Hematopoietic Cellular Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $781,263 | February 1, 2020 | January 31, 2026 | ZINTER, MATTHEW SCOTT | reporter.nih.gov |
| Basal Progenitor Cells and Eosinophilic Esophagitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $780,597 | April 1, 2014 | January 31, 2023 | QUE, JIANWEN | reporter.nih.gov |
| Impact of Anemia and Its Treatment on Gut Injury in Preterm Infants | NIH | National Heart, Lung, and Blood Institute | 2023 | $780,398 | September 1, 2023 | May 31, 2025 | JOSEPHSON, CASSANDRA D | reporter.nih.gov |
| Engineering an Islet Thread from zwitterionically modified alginates for type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $778,391 | July 1, 2018 | April 30, 2025 | MA, MINGLIN | reporter.nih.gov |
| Genetic regulation of active and reserve intestinal stem cell states | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $775,304 | September 19, 2019 | June 30, 2023 | MAGNESS, SCOTT T | reporter.nih.gov |
| Role of IL-10R signaling in inflammation induced exhaustion of HSC and emergence of JAK2V617F clonal hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $773,862 | September 25, 2022 | June 30, 2025 | FLEISCHMAN, ANGELA GOFFREDO | reporter.nih.gov |
| Stem Cell-based Platform for Targeted Enzyme/Prodrug Therapy of Recurrent Ovarian Cancer | NIH | National Cancer Institute | 2021 to 2022 | $771,552 | April 1, 2021 | March 31, 2023 | HATEFI, ARASH | reporter.nih.gov |
| Juvenile microRNAs promoting healthier adult aging | NIH | National Institute on Aging | 2021 to 2022 | $770,000 | April 1, 2018 | March 31, 2023 | SLACK, FRANK J. | reporter.nih.gov |
| Immune Compromised Zebrafish for Cell Transplantation | NIH | Office of the Director, National Institutes of Health | 2021 | $769,909 | August 1, 2013 | June 30, 2022 | LANGENAU, DAVID MICHAEL | reporter.nih.gov |
| Anti-CD38 targeted alpha emitter radioimmunotherapy to eliminate multiple myeloma | NIH | National Cancer Institute | 2022 to 2023 | $769,415 | March 8, 2017 | December 31, 2023 | GREEN, DAMIAN J. | reporter.nih.gov |
| Oxygen generating bioinks for 3D printed bone implants | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $768,975 | September 17, 2018 | June 30, 2024 | SHIN, SU RYON | reporter.nih.gov |
| Controlling Influences of Oxygen Tension and CD26/DPP4 Enzymatic Activity on Regulation of Hematopoietic Stem/Progenitor Cells and Hematopoiesis During Health, Ageing, and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $768,104 | May 1, 2018 | April 30, 2022 | BROXMEYER, HAL E. | reporter.nih.gov |
| Stem cell self-renewal programs in rhabdomyosarcoma | NIH | National Cancer Institute | 2021 to 2022 | $763,179 | January 10, 2018 | December 31, 2022 | LANGENAU, DAVID MICHAEL | reporter.nih.gov |
| DNA Methylation at N6-Adenine in Placental Trophoblast Development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $761,382 | August 1, 2020 | September 30, 2022 | JIANG, ZONGLIANG | reporter.nih.gov |
| Pericyte Mechanisms in Traumatic Brain Injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $761,262 | June 15, 2018 | March 31, 2024 | LO, ENG H. | reporter.nih.gov |
| Identifying the human skeletal stem cell. | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $761,230 | August 6, 2018 | July 31, 2024 | LONGAKER, MICHAEL T | reporter.nih.gov |
| Biosynthetic Metabolic Pathway Regulation of Glioma Growth | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $758,612 | December 15, 2017 | November 30, 2023 | HJELMELAND, ANITA BORTON | reporter.nih.gov |
| Regulation of Metastatic Development by Heritable Variants in the Tumor Microenvironment | NIH | National Cancer Institute | 2021 to 2023 | $758,560 | December 1, 2017 | November 30, 2024 | HURLEY, PAULA JILL | reporter.nih.gov |
| Functional Activation and Targeting of Exosomes for Regenerative Medicine | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $755,728 | July 15, 2018 | May 31, 2025 | RAVINDRAN, SRIRAM | reporter.nih.gov |
| The role of BCAM-positive cells in central cornea, limbus and conjunctiva | NIH | National Eye Institute | 2024 | $753,189 | August 1, 2024 | May 31, 2029 | SASAMOTO, YUZURU | reporter.nih.gov |
| Identifying and characterizing human pulmonary neuroendocrine stem cells and their diversity | NIH | National Heart, Lung, and Blood Institute | 2024 | $752,555 | September 24, 2024 | August 31, 2025 | KUO, CHRISTIN SUCHENG | reporter.nih.gov |
| Alleviating Reactive Carbonyl Species-Induced Progenitor Cell Dysfunction in Diabetic Wound Healing | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $749,504 | August 2, 2019 | July 31, 2024 | WANG, JIEMEI | reporter.nih.gov |
| Mechanisms and targeting of inflammatory cytokine-driven expansion and progression in AML | NIH | National Cancer Institute | 2021 to 2023 | $749,285 | March 1, 2019 | February 28, 2025 | AGARWAL, ANUPRIYA | reporter.nih.gov |
| Hyperpolarized Micro-NMR for Quantitative Analysis of Metabolism in Leukemia Stem Cells | NIH | National Cancer Institute | 2021 to 2023 | $747,000 | March 1, 2018 | December 31, 2024 | JEONG, SANGMOO | reporter.nih.gov |
| A universal genome editing strategy to develop an airway stem cell therapy for cystic fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $747,000 | September 1, 2022 | August 31, 2025 | VAIDYANATHAN, SRIRAM | reporter.nih.gov |
| Characterizing the pathogenesis and targeted therapeutics of Wilms' Tumor 1 (WT1) mutations in AML | NIH | National Cancer Institute | 2021 to 2023 | $746,999 | April 1, 2019 | July 31, 2024 | ZHANG, HAIJIAO | reporter.nih.gov |
| MicroRNAs, ER Stress and Arsenic Neurotoxicity | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $746,994 | February 5, 2021 | January 31, 2025 | PARK, HAE-RYUNG | reporter.nih.gov |
| Nanowired human isogenic cardiac organoids to treat acute myocardial ischemia/reperfusion injuries | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $745,982 | August 1, 2023 | July 31, 2025 | MEI, YING | reporter.nih.gov |
| Bioactive cellulose-nanodiamond (CeND) scaffolds for applications in craniofacial bone tissue regeneration | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $745,000 | September 1, 2019 | August 31, 2025 | NICOLAU, EDUARDO | reporter.nih.gov |
| Prometastatic Effects of Neoadjuvant Chemotherapy in Breast Cancer | NIH | National Cancer Institute | 2022 to 2024 | $744,673 | September 14, 2022 | August 31, 2025 | KARAGIANNIS, GEORGE S | reporter.nih.gov |
| Exercise-induced skeletal muscle exosomes promote adipocyte lipolysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $744,574 | September 19, 2018 | July 31, 2024 | MCCARTHY, JOHN JOSEPH | reporter.nih.gov |
| Hematopoietic Stem Cell And Cord Blood Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $743,524 | September 30, 2005 | March 31, 2022 | PETERSDORF, EFFIE W | reporter.nih.gov |
| Screening for DNA Damage Response Modulators in Glioblastoma Stem Cells | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $742,584 | September 15, 2020 | July 31, 2025 | BADR, CHRISTIAN ELIAS | reporter.nih.gov |
| (PQ4) - Tools for simultaneous disruption of multiple epigenetically silenced genes for studying their roles in tumorigenesis using ex vivo human and mouse colon organoid and in vivo mouse models | NIH | National Cancer Institute | 2021 to 2022 | $741,665 | September 1, 2018 | August 31, 2024 | EASWARAN, HARIHARAN | reporter.nih.gov |
| Targeting CD83 to reduce leukemia relapse and GVHD after allogeneic hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 | $741,625 | April 1, 2023 | August 31, 2023 | BETTS, BRIAN C | reporter.nih.gov |
| Granulocyte-Macrophage Colony Stimulated Factor (GM-CSF) in Peripheral Arterial Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $740,646 | August 15, 2017 | July 31, 2024 | QUYYUMI, ARSHED A | reporter.nih.gov |
| Polysaccharide putty formulations for tissue regeneration | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2024 | $740,633 | July 1, 2023 | December 31, 2024 | KUMBAR, SANGAMESH GURAPPA | reporter.nih.gov |
| Understanding the Role of Somatic Mutations in Adult Inflammatory Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $739,530 | January 1, 2022 | December 31, 2025 | BECK, DAVID | reporter.nih.gov |
| Targeting tumor and its microenvironment using nanotherapeutics for pancreatic cancer | NIH | National Cancer Institute | 2021 to 2022 | $737,469 | August 1, 2020 | September 30, 2022 | RACHAGANI, SATYANARAYANA | reporter.nih.gov |
| Dissecting gene dysregulation at the maternal-fetal interface in preeclampsia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $737,270 | July 1, 2018 | December 31, 2023 | FISHER, SUSAN J. | reporter.nih.gov |
| Targeting tumor and its microenvironment using nanotherapeutics for pancreatic cancer | NIH | National Cancer Institute | 2023 to 2024 | $736,832 | August 1, 2020 | April 30, 2026 | RACHAGANI, SATYANARAYANA | reporter.nih.gov |
| Targeting Metabolic Liabilities of Leukemia-Initiating Cells | NIH | National Cancer Institute | 2021 to 2023 | $733,740 | February 1, 2019 | March 31, 2023 | XU, JIAN | reporter.nih.gov |
| Highly Specific ZFN-Based HSC Gene Editing Therapies Identified By In Vivo Barcode Nanoparticle Screens And Rationally Designed Mrna | NIH | National Center for Advancing Translational Sciences | 2021 | $733,169 | September 16, 2019 | September 14, 2022 | DAHLMAN, JAMES | reporter.nih.gov |
| Targeted inactivation of HIV in CNS reservoirs | NIH | National Institute of Mental Health | 2021 | $732,093 | April 20, 2017 | January 31, 2023 | CANNON, PAULA M | reporter.nih.gov |
| The role of glutaminolysis as a therapeutic target in T-ALL | NIH | National Cancer Institute | 2021 to 2022 | $727,426 | July 1, 2019 | June 30, 2023 | HERRANZ, DANIEL | reporter.nih.gov |
| The Role of Wnt2b in Intestinal Health | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $726,020 | January 15, 2020 | December 31, 2024 | OCONNELL, AMY E | reporter.nih.gov |
| Crosstalk between leukemic blasts and the BM microenvironment contribute to leukemic transformation | NIH | National Cancer Institute | 2022 to 2023 | $725,739 | March 4, 2022 | March 2, 2023 | DORRANCE, ADRIENNE M. | reporter.nih.gov |
| Functional validation of sequence variants affecting neurodevelopmental and craniofacial phenotypes | NIH | National Institute of Dental & Craniofacial Research | 2022 | $725,353 | September 26, 2022 | September 30, 2025 | CORCES, VICTOR G. | reporter.nih.gov |
| Dissecting the Roles and Requirements for RBM39 in Acute Myeloid Leukemia and Normal Hematopoiesis | NIH | National Cancer Institute | 2022 to 2024 | $724,902 | July 1, 2022 | June 30, 2025 | LU, SYDNEY X | reporter.nih.gov |
| 3D Bioprinting of Biomimetic Constructs for Rotator Cuff Augmentation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $720,530 | June 1, 2018 | October 31, 2024 | DUAN, BIN | reporter.nih.gov |
| Prognostic biomarkers for respiratory failure post hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $719,304 | September 1, 2020 | July 31, 2025 | ROWAN, COURTNEY | reporter.nih.gov |
| Hematopoietic stem cell gene therapy for infantile neuronal ceroid lipofuscinosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $717,826 | August 21, 2018 | April 30, 2023 | WILLIAMS, DAVID A | reporter.nih.gov |
| Computational approaches for identifying epigenomic contexts of somatic mutations | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $715,500 | April 1, 2019 | March 31, 2023 | DE, SUBHAJYOTI | reporter.nih.gov |
| Bispecific and Trispecific Anti-Env Antibodies for Eliminating HIV Reservoir Cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $713,872 | July 10, 2017 | June 30, 2023 | HO, DAVID D | reporter.nih.gov |
| Molecular mechanisms for bone marrow failure and clonal progression during the innate immune response in Fanconi Anemia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $711,302 | April 1, 2019 | January 31, 2024 | EKLUND, ELIZABETH ANN | reporter.nih.gov |
| Environmental Arsenic in the Subtype Specification of Breast Cancer | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $710,620 | June 30, 2020 | August 31, 2024 | BONINI, MARCELO G. | reporter.nih.gov |
| Use of forward Genetic approaches to identify Babesia receptors | NIH | National Heart, Lung, and Blood Institute | 2021 | $710,081 | December 15, 2017 | November 30, 2022 | LOBO, CHERYL ANN | reporter.nih.gov |
| The role of inflammation in driving leukemogenesis in germline predisposition syndromes | NIH | National Cancer Institute | 2022 | $707,850 | May 1, 2022 | April 30, 2023 | GODLEY, LUCY ANN | reporter.nih.gov |
| Personalized vaccine for patients with AML | NIH | National Cancer Institute | 2021 to 2022 | $707,845 | December 9, 2016 | May 31, 2024 | AVIGAN, DAVID E. | reporter.nih.gov |
| The Functional Role of LGR5 in Colon Cancer | NIH | National Cancer Institute | 2021 to 2022 | $706,563 | April 1, 2017 | January 31, 2024 | WANG, JING | reporter.nih.gov |
| A Human Organoid Model of Polycystic Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $706,000 | September 15, 2018 | June 30, 2023 | FREEDMAN, BENJAMIN SOLOMON | reporter.nih.gov |
| Mechanisms and therapeutic targeting of colon cancer stem cell plasticity | NIH | National Cancer Institute | 2021 to 2022 | $704,550 | April 1, 2018 | March 31, 2025 | CARMON, KENDRA S. | reporter.nih.gov |
| Regulation of Lipid Catabolism by Autophagy in Neural Stem Cell of Tuberous Sclerosis Complex | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $702,188 | July 15, 2018 | June 30, 2024 | WANG, CHENRAN | reporter.nih.gov |
| Developing an optimized cell based platform for assays of the gastrointestinal enteroendocrine system | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $699,341 | August 1, 2019 | June 30, 2023 | SIMS, CHRISTOPHER ELDRIDGE | reporter.nih.gov |
| Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $697,812 | December 1, 2017 | November 30, 2023 | SIM, FRASER JAMES | reporter.nih.gov |
| Hyperbaric oxygen to improve blood count recovery in Auto-HCT for myeloma | NIH | National Cancer Institute | 2021 to 2022 | $695,162 | April 1, 2018 | March 31, 2025 | ALJITAWI, OMAR | reporter.nih.gov |
| Direct and Indirect Neurogenesis in the Mammalian Neocortex | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $693,662 | May 1, 2024 | April 30, 2029 | HAYDAR, TARIK F | reporter.nih.gov |
| A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia | NIH | National Heart, Lung, and Blood Institute | 2022 | $692,343 | April 1, 2022 | March 31, 2023 | WILLIAMS, DAVID A | reporter.nih.gov |
| Hematopoietic Stem Cell Gene Therapy for Friedreich's ataxia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $691,250 | September 1, 2018 | June 30, 2023 | CHERQUI, STEPHANIE | reporter.nih.gov |
| Genotypic Interactions in Brain Cancer Heterogeneity | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $690,794 | September 1, 2012 | January 31, 2023 | FURNARI, FRANK | reporter.nih.gov |
| Understanding how ZFHX4 drives the glioblastoma tumor propagating cell state | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $689,062 | July 1, 2018 | May 31, 2024 | CHHEDA, MILAN GIRISH | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 6 | $17,185,732 | 0 | $0 |
| 2024 | 328 | $146,218,932 | 0 | $0 |
| 2023 | 540 | $233,704,184 | 0 | $0 |
| 2022 | 699 | $302,467,213 | 0 | $0 |
| 2021 | 840 | $372,689,177 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 2 awards here | |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.839 | December 3, 2026 | Not listed | Same assistance listing 93.839 as 115 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.839 | December 3, 2026 | Not listed | Same assistance listing 93.839 as 115 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.839 | December 4, 2026 | Not listed | Same assistance listing 93.839 as 115 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.839 | January 5, 2027 | Not listed | Same assistance listing 93.839 as 115 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.839 | January 5, 2027 | Not listed | Same assistance listing 93.839 as 115 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.839 | January 7, 2027 | $375,000 | Same assistance listing 93.839 as 115 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.839 | January 7, 2027 | Not listed | Same assistance listing 93.839 as 115 awards here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) | PAR-25-025 | NIH | 93.839 | February 3, 2027 | $1.5 million | Same assistance listing 93.839 as 115 awards here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) | PAR-25-026 | NIH | 93.839 | February 3, 2027 | Not listed | Same assistance listing 93.839 as 115 awards here |
| Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) | PAR-27-125 | NIH | 93.839 | February 16, 2027 | Not listed | Same assistance listing 93.839 as 115 awards here |
| Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed) | RFA-DK-27-108 | NIH | 93.839 | March 10, 2027 | $500,000 | Same assistance listing 93.839 as 115 awards here |
| NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) | PAR-25-032 | NIH | 93.839 | March 16, 2027 | Not listed | Same assistance listing 93.839 as 115 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.839 | April 5, 2027 | Not listed | Same assistance listing 93.839 as 115 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.839 | April 5, 2027 | Not listed | Same assistance listing 93.839 as 115 awards here |
| Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed) | RFA-OD-25-003 | NIH | 93.839 | April 9, 2027 | $200,000 | Same assistance listing 93.839 as 115 awards here |
| NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) | RFA-HL-26-002 | NIH | 93.839 | April 28, 2027 | Not listed | Same assistance listing 93.839 as 115 awards here |
| NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) | RFA-HL-26-003 | NIH | 93.839 | April 28, 2027 | Not listed | Same assistance listing 93.839 as 115 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) | PA-24-175 | NIH | 93.839 | May 7, 2027 | Not listed | Same assistance listing 93.839 as 115 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.839 | May 7, 2027 | Not listed | Same assistance listing 93.839 as 115 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.